









Interaction Between Smoking and Body Weight:  









A dissertation submitted in partial fulfillment 
of the requirements for the degree of  
Doctor of Philosophy 
(Health Services Organization and Policy) 








Doctoral Committee:  
 
Associate Professor David Mendez, Chair 
Assistant Professor Katherine W. Bauer 
Professor Edward C. Norton 


















ORCID iD: 0000-0001-8412-7727 
 
 






































TABLE OF CONTENTS 
 
DEDICATION  ii 
LIST OF TABLES  v 





I. Age-Specific Changes in BMI and BMI Distribution Among US Adults Using Cross-
Sectional Surveys from 1997 to 2017 
  1.1 Background  7 
  1.2 Methods  9 
  1.3 Results  12 
  1.4 Discussion  16 
  References  19 
  Tables and Figures  22 
 
II. Comparing Benefits of Quitting vs Harm Due to Post-Cessation Weight Gain: Evaluating 
Potential Break-Even Scenarios 
  2.1 Background  31 
  2.2 Methods  34 
  2.3 Results  41 
  2.4 Sensitivity Analysis  44 
  2.5 Discussion  44 
  References  47
 iv 
 
  Tables and Figures  50 
  Appendices  62 
 
III. Estimating Health Benefits Gained from Reduction in Post-Cessation Weight Gain: An 
Agent-Based Modelling Approach  
  3.1 Background  87 
  3.2 Methods  90 
  3.3 Model  94 
  3.4 Results  97 
  3.5 Discussion  100 
  References  103 
  Tables and Figures  107 


























LIST OF TABLES 
Chapter 1 
Table 1.1 Mean BMI by age and gender for matched synthetic cohorts across two periods.  22 
Table 1.2 BMI changes by age and gender for matched synthetic cohorts between two periods. 23 
 
Chapter 2 
Table 2.1 Group Prevalence adjusted for smoking and weight statuses by gender, race and 50 
age.    
Table 2.2 Relative risk (RR) adjusted for smoking and weight statuses by gender.    51 
Table 2.3 Age-specific annual mortality rates for normal-weight never-smokers by gender and 52 
And race. 
Table 2.4 Baseline characteristics of the sample population, Health and Retirement Study         53 
1992. 
Table 2.5 Regression results for change in BMI (%) under Model I, Model II and                      54 
Model III. 
Table 2.A.1 Break-even weight gain in BMI units for males with high SES under permanent    62 
weight gain. 
Table 2.A.2 Break-even weight gain in BMI units for females with high SES under                   63 
permanent weight gain. 
Table 2.B.1 Break-even weight gain in BMI units for smokers with low SES under permanent  64 
weight gain.  
Table 2.B.2 Break-even weight gain in BMI units for females with low SES under permanent 65 
weight gain.  
Table 2.C.1 Break-even weight gain in BMI units for smokers with low SES under  66 
diminishing weight gain. 
Table 2.D.1 Break-even weight gain in BMI units for males with high SES under permanent  67 
weight gain (Model II). 
Table 2.D.2 Break-even weight gain in BMI units for females with high SES under permanent  68 
weight gain (Model II). 
Table 2.D.3 Break-even weight gain in BMI units for males with low SES under permanent  69 
weight gain (Model II). 
Table 2.D.4 Break-even weight gain in BMI units for females with low SES under permanent  70 
weight gain (Model II). 
Table 2.D.5 Break-even weight gain in BMI units for males with high SES under permanent  71 
weight gain (Model III). 
Table 2.D.6 Break-even weight gain in BMI units for females with high SES under permanent  72 
weight gain (Model III). 
Table 2.D.7 Break-even weight gain in BMI units for males with low SES under permanent  73 
weight gain (Model III). 
Table 2.D.8 Break-even weight gain in BMI units for females with low SES under permanent  74 
weight gain (Model III). 
 vi 
 
Table 2.D.9 Break-even weight gain in BMI units for smokers with high SES under 75 
diminishing weight gain (Model II).  
Table 2.D.10 Break-even weight gain in BMI units for smokers with low SES under 76 
diminishing weight gain (Model II).  
Table 2.D.11 Break-even weight gain in BMI units for smokers with high SES under 77 
diminishing weight gain (Model III).  
Table 2.D.12 Break-even weight gain in BMI units for smokers with low SES under 78 
diminishing weight gain (Model III).  
Table 2.E.1 Sensitivity analysis of average break-even weight gain (BMI) for white males 79 
under permanent weight gain. 
Table 2.E.2 Sensitivity analysis of average break-even weight gain (BMI) for white females 80 
under permanent weight gain. 
Table 2.E.3 Sensitivity analysis of average break-even weight gain (BMI) for black males 81 
under permanent weight gain. 
Table 2.E.4 Sensitivity analysis of average break-even weight gain (BMI) for black females 82 
under permanent weight gain. 
Table 2.E.5 Sensitivity analysis of average break-even weight gain (BMI) for white males 83 
under diminishing weight gain. 
Table 2.E.6 Sensitivity analysis of average break-even weight gain (BMI) for white females 84 
under diminishing weight gain. 
Table 2.E.7 Sensitivity analysis of average break-even weight gain (BMI) for black males 85 
under diminishing weight gain. 
Table 2.E.8 Sensitivity analysis of average break-even weight gain (BMI) for black females 86 
under diminishing weight gain. 
  
Chapter 3 
Table 3.1 Baseline characteristics of adult smokers in the simulated cohort vs the National 107 
Health Interview Survey, 2017. 
Table 3.2 Age-specific annual mortality rates for normal-weight never-smokers by gender 108 
and race. 
Table 3.3 Summary of interventions.  109 
Table 3.4 Value of parameters in the model estimating effectiveness of interventions. 110 
Table 3.5 Cumulative survival probability in Scenario I, where all smokers quit. 111 
Table 3.6 Average obesity prevalence in Scenario I, where all smokers quit. 112 
Table 3.7 Cumulative survival probability in Scenario II, where status quo cessation rate is 113 
4.5%.  
Table 3.8 Life-Years Saved in Scenario II compared with status quo, where status quo 114 
cessation rate is 4.5%. 
Table 3.9 Average obesity prevalence in Scenario II, where status quo cessation rate is 4.5%. 115 
Table 3.A.1 Baseline characteristics of the sample population, Health and Retirement 119 
Study 1992.  







LIST OF FIGURES 
 
Chapter 1 
Figure 1.1 Age-specific increase in mean BMI between 1997-2007 and 2007-2017 for men.  24 
Figure 1.2 Age-specific increase in mean BMI between 1997-2007 and 2007-2017 for women. 25 
Figure 1.3 Change in BMI distribution between 2007 and 2017 by age cohorts for men.  26 
Figure 1.4 Change in BMI distribution between 2007 and 2017 by age cohorts for women. 27 
Figure 1.5 Change in BMI across the BMI spectrum for men and women over two periods. 28 
Figure 1.6 Age-specific change in BMI for men and women between 2007 and 2017,      29 
stratified by household income. 
Figure 1.7 Age-specific change in BMI for men and women between 2007 and 2017, 30 
stratified by smoking behaviors. 
 
Chapter 2 
Figure 2.1 Flowchart for selecting eligible participants in the final sample from the Health        55 
and Retirement Study. 
Figure 2.2 Simulated life-time BMI trajectory for a white male with an initial BMI of 25 at  56 
age 50, assuming different smoking behaviors. 
Figure 2.3 Survival curves for current smoker vs former smoker I vs former smoker II from 57 
age 50 to 100. 
Figure 2.4 Average break-even weight gain (BMI) by gender, race and quit-age under               58 
permanent weight gain.   
Figure 2.5 Break-even weight gain (lbs) at quit-age 80 by gender, race and initial BMI  59 
under diminishing weight-gain. 
Figure 2.6 Total life-years saved for white males with no post-cessation weight gain vs  60 
average post-cessation weight gain with known initial BMI at age 50. 
 
Chapter 3 
Figure 3.1 Flowchart for selecting eligible participants in the final sample from the Health 116 
and Retirement Study. 
Figure 3.2 Average cumulative survival probability in one-year increments under the random 117 
sample in Scenario I, where all smokers quit.  
Figure 3.3 Average obesity prevalence in one-year increments under the random sample in  118 
Scenario I, where all smokers quit.  
Figure 3.D.1 Average cumulative survival probability under the NHIS sample in Scenario I, 123 
status quo vs electronic cigarette.  
Figure 3.D.2 Average cumulative survival probability under the NHIS sample in Scenario I, 123 
status quo vs physical activity.  
Figure 3.D.3 Average obesity prevalence under the NHIS sample in Scenario I, status quo 124 
vs electronic cigarette.  
Figure 3.D.4 Average obesity prevalence under the NHIS sample in Scenario I, status quo 124
 viii 
 
vs physical activity.  
Figure 3.E.1 Average cumulative survival probability under the random sample in 125 
Scenario II, status quo vs pharmacotherapy.  
Figure 3.E.2 Average cumulative survival probability under the random sample in 125 
Scenario II, status quo vs electronic cigarette.  
Figure 3.E.3 Average cumulative survival probability under the random sample in 126 
Scenario II, status quo vs physical activity.  
Figure 3.E.4 Average obesity prevalence under the random sample in Scenario II, status  126 
quo vs pharmacotherapy.  
Figure 3.E.5 Average obesity prevalence under the random sample in Scenario II, status 127 
quo vs electronic cigarette.  
Figure 3.E.6 Average obesity prevalence under the random sample in Scenario II, status 127 
quo vs physical activity.  
Figure 3.E.7 Average cumulative survival probability under the NHIS sample in Scenario II, 128 
status quo vs pharmacotherapy.  
Figure 3.E.8 Average cumulative survival probability under the NHIS sample in Scenario II, 128 
status quo vs electronic cigarette.  
Figure 3.E.9 Average cumulative survival probability under the NHIS sample in Scenario II, 129 
status quo vs physical activity.  
Figure 3.E.10 Average obesity prevalence under the NHIS sample in Scenario II, status 129 
quo vs pharmacotherapy. 
Figure 3.E.11 Average obesity prevalence under the NHIS sample in Scenario II, status 130 
quo vs electronic cigarette. 
Figure 3.E.12 Average obesity prevalence under the NHIS sample in Scenario II, status 130 






















Cigarette consumption and excess weight are the two leading causes of premature death and 
disability in the US. Smoking cessation has well-documented health benefits. However, 80% of 
quitters experience an unintended consequence of quitting: post-cessation weight gain. Currently, 
the health message provided to smokers is that it is never too late to quit, without addressing the 
weight concern that many have.  
 
I outline three papers in this dissertation to study the interaction of smoking behaviors and body 
weight. The first paper examines the age-specific changes in BMI and BMI distribution among US 
adults, adjusting for smoking and socioeconomic status (SES). I examine population representative 
annual BMI change across two time periods (1997 to 2007 and 2007 to 2017) by age, gender, SES 
and smoking status using a synthetic cohort approach. I also assess the changes in BMI distribution 
among age-specific groups. Information on BMI change and BMI distribution change can help us 
identify age-groups that are more susceptible to excess weight gain. The second study investigates 
the tradeoff between the health benefits of quitting smoking and the harm due to post-cessation 
weight gain. I estimate the break-even weight gain, i.e. the weight individuals would need to gain 
to offset the benefits of smoking cessation. A potentially attainable break-even weight gain exists 
for certain combinations of quit-age and BMI. The break-even weight gain decreases with quit-
age. The break-even weight gain for white males with an initial BMI of 30 is 29.9 kg if they quit 
at 50 but decreases to 4.2 kg if they quit 80. I identify subgroups with higher initial BMI and higher 
cigarette consumption as high-risk to receive negative net health benefits from quitting. Smoking 
 x 
 
cessation should be coupled with weight management programs to maximize health gains. Lastly, 
I explore interventions that could reduce post-cessation weight gain and estimate the potential 
increase of overall welfare in the population. Employing an agent-based model, I simulate three 
interventions on a nationally representative sample of US smokers: pharmacotherapy, physical 
activity intervention and alternative tobacco product (electronic cigarette). These interventions 
affect both smoking cessation rates and post-cessation weight gain. Model results show that 












The two leading causes of premature death and disability in the US are cigarette consumption and 
excess weight [1]. It is well known that smoking can lead to many adverse health conditions such 
as cardiovascular diseases, lung cancer and exacerbation of multiple chronic health conditions [2]. 
Tobacco smoking has remained the leading preventable cause of disease and premature death in 
the US [3,4]. According to the Surgeon General’s Report on smoking in 2014, the estimated annual 
smoking-attributable death is around 480,000 [4]. Policy-makers have implemented interventions 
to either prevent non-smokers from initiating or encourage smokers to quit. Common interventions 
include cigarette excise taxes, smoke-free air laws, nicotine replacement treatment and cognitive 
behavioral therapy [5-8].  
 
Smoking cessation benefits not only individual smokers, but also the society as a whole. Studies 
have found that the all-cause mortality rate is about three times among smokers compared to those 
who have never smoked [9]. More specifically, the relative risk of mortality for smokers is around 
25 for lung cancer, 2 from renal failure, 6 from intestinal ischemia, 2.4 from hypertensive heart 
disease, 2.3 from infections and 2 from various respiratory diseases [2,10]. In addition, life 
expectancy was shortened by more than 10 years among current smokers compared to non-
smokers. Adults who quit smoking between ages 25 to 54 gain around 8.5 years of life on average 
compared with those who continued to smoke [9].  Smoking cessation is also associated with a  
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considerable and rapid benefit in decreasing the risk of stroke, particularly in light smokers (<20 
cigarettes /d) [11].  It is estimated that cigarette smoking costs the US 96 billion in direct medical 
expense and $97 billion in lost productivity per year [12]. 
 
However, there are some side effects of smoking cessation. For example, smokers who attempt to 
quit, experience nicotine withdrawal symptoms such as headaches, depression and anxiety [13]. 
In addition, smokers generally gain weight when they quit smoking [14-18]. This is due to the 
effect of nicotine on the body. Nicotine accelerates the baseline metabolism rate and suppresses 
appetite. Once it is removed, the baseline metabolism rate decreases and food consumption 
increases, resulting in excess weight [15]. Using the 2003 - 2012 National Health and Nutrition 
Examination Survey (NHANES), Veldheer et al. found that the mean 10-year weight gain among 
continuing smokers was 3.5 kg (7.7 lbs.) versus 8.4 kg (18.5 lbs.) among former smokers after 
controlling for age, gender, education and race [18]. The potential weight gain associated with 
smoking can lessen some of the health benefits of quitting.  
 
While most people gain weight after smoking cessation, there is considerable variance in the 
amount of weight gain. A meta-analysis done by Aubin et al. in 2012 found, from 62 studies, the 
mean weight gain was 4.67 kg (10.3 lbs) at 12 months after quitting. But around 13% of quitters 
gained more than 10 kg (22 lbs) [19]. Another meta-analysis done by Tian et al. in 2015 identified 
35 cohort studies, including 63,403 quitters and 388,432 smokers. The mean weight gain was 4.10 




I outline three papers to study the interaction of smoking behaviors and weight. Briefly, the first 
paper examines the age-specific changes in BMI and BMI distribution among US adults, adjusting 
for smoking and socioeconomic status (SES). The second study investigates the tradeoff between 
the health benefits of quitting smoking and the harm due to post-cessation weight gain. Lastly, I 
explore interventions that could reduce post-cessation weight gain and estimate the potential 
increase of overall welfare in the population.  
 
Chapter 1: What are the age-specific changes in BMI and BMI distribution among US adults? 
Does either smoking behaviors or socioeconomic status affect the BMI changes?  
While many studies investigated trends in obesity or BMI trajectories, they failed to address the 
BMI changes across the BMI spectrum or whether a period effect exists across birth cohorts. In 
the first paper, I examine population representative annual BMI change across two time periods 
(1997 to 2007 and 2007 to 2017) by age, gender, SES and smoking status using a synthetic cohort 
approach. I also assess the changes in BMI distribution among age-specific groups. Information 
on BMI change and BMI distribution change can help us identify age-groups that are more 
susceptible to excess weight gain.  
 
Chapter 2: Can the harm from post-cessation weight gain completely offset the benefits from 
smoking cessation?  
Using survival analysis, I calculate the tradeoff between smoking cessation and post-cessation 
weight gain using mean survival time. I estimate the break-even weight gain, i.e. the weight 
individuals would need to gain to offset the benefits of smoking cessation. A potentially attainable 
break-even weight gain exists for certain combinations of quit-age and BMI. The break-even 
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weight gain decreases with quit-age. The break-even weight gain for white males with an initial 
BMI of 30 is 29.9 kg if they quit at 50 but decreases to 4.2 kg if they quit 80. I identify subgroups 
with higher initial BMI and higher cigarette consumption as high-risk to receive negative net health 
benefits from quitting. Compared with smokers who experience no post-cessation weight gain, 
those who experience an average post-cessation weight gain lose 0.64 life-years saved from 
quitting. Smoking cessation should be coupled with weight management programs to maximize 
health gains. 
 
Chapter 3. Can some interventions help smokers quit while reducing post-cessation weight gain? 
How much health benefits can quitters potentially gain? 
In this study, I estimate the health benefits gained from reduction in post-cessation weight gain 
using an agent-based model. The model simulates three interventions from different categories: 
pharmacotherapy, physical activity intervention and alternative tobacco product (electronic 
cigarette). The effectiveness of these interventions is assessed in terms of cumulative survival 
probability, life-years saved and obesity prevalence at the population level. I first simulate a 
nationally representative sample of adult smokers in the US via the National Health Interview 
Survey (NHIS) in 2017. Then interventions affecting both smoking cessation rates and post-
cessation weight gain are implemented among the simulated population. Model results show that 
electronic cigarette is the dominant intervention that increases survival probability and reduces 
obesity prevalence. If all adult smokers quit smoking and switch to electronic cigarette, they will 
experience a 1.25 percentage points increase in cumulative survival rate and 3.11 percentage points 
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Age-Specific Changes in BMI and BMI Distribution Among US Adults Using 
Cross-Sectional Surveys From 1997 to 2017 
 
1.1 Background 
Globally the obesity prevalence is growing at an alarming rate with around 2 billion individuals 
overweight and one third of them obese [1]. Similar to many countries, the adult obesity prevalence 
in the US has increased in the past few decades. In 2015, the obesity prevalence was around 40% 
among US adults, compared with 30% in 1999 [2].  
 
Obesity is a result of excess weight gain from imbalance between energy intake and consumption. 
It is associated with adverse health conditions such as heart disease, stroke, type2 diabetes and 
certain types of cancer [3,4]. Studies have shown that obesity affects some groups more than others. 
For example, obesity is closely associated with age. Adults between the age 40 and 59 tend to have 
higher obesity prevalence than other age groups [2]. Race is another important factor. Hispanic 
and non-Hispanic black adults have higher obesity prevalence than non-Hispanic white adults [2, 
5]. In addition, obesity prevalence varies by socioeconomic status (SES) and smoking status [6,7]. 
Individuals with lower income or less education (less than high school) tend to have a higher 
prevalence of obesity [7]. Smoking initiation is associated with weight loss and smoking cessation 





Some studies have addressed changes in BMI or BMI trajectories over time. For example, 
Nonnemaker et al. examined seven rounds of the 1997 National Longitudinal Survey of Youth to 
examine BMI trajectories among youth. They identified the BMI trajectories into four classes 
based on risk of becoming obese by adulthood and discovered some variables that are potentially 
associated with class membership such as race, gender and mother’s education [10]. Another study 
using the Quebec Longitudinal Study of Child Development followed 2,210 children for 8 years. 
Researchers were able to identify three trajectories of BMI. For the group with an increasing 
average BMI, maternal BMI and maternal smoking during pregnancy are strongly associated with 
the group [11]. While most studies examined BMI trajectories for children or adolescents [10-14], 
some also investigated BMI trajectories in adulthood. Peralta et al. assessed association of BMI 
trajectories from 34 to 54 years with lung function decline. They found that overweight and obese 
trajectories of BMI decreased lung function [15]. A recent publication by Song et al. examined the 
influence of genes on BMI trajectory in adulthood. They created a genetic risk score and 
discovered a nonlinear association between the score and BMI over time [16].  
 
However, most studies focus on trends in obesity prevalence or changes in mean BMI. They do 
not address BMI changes across the spectrum or whether a period effect exists across birth cohorts 
[10-12,16]. In addition, previous studies tend to cover a fraction of adulthood instead of examining 
changes in the BMI distribution over an extended age period [15]. This study contributes to the 
literature by examining the age- and gender-specific changes in BMI and BMI distribution over 
adulthood (20-65) and across two time periods (1997- 2007 and 2007-2017). Factors that might 




in BMI and BMI distribution can help us identify subgroups that are more susceptible to excess 
weight gain.  
 
1.2 Methods 
I adopted a synthetic cohort approach to examine longitudinal changes in adult BMI and BMI 
distribution across two time periods: 1997 to 2007, and 2007 to 2017.  Synthetic cohort approach 
constructs a pseudo panel from multiple cross-sectional surveys by matching participants by birth 
year. It is a popular tool used by econometricians and epidemiologists when there is a lack of panel 
data [17,18].  
 
Sample 
I combined three waves of the National Health Interview Survey (NHIS) to construct the synthetic 
cohort. NHIS has monitored the health of US population since 1957. It was conducted every year 
on a nationally representative sample of the population and the data was collected by the US 
Census Bureau. My sample included survey years 1997, 2007 and 2017 for the synthetic cohort 
analysis.  
 
The final sample excluded women who were pregnant at the survey, individuals with missing BMI 
information and individuals under the age of 20.  The sample size is 33,645 in 1997, 21,220 in 







Mean BMI change by age and sex  
Mean BMI was determined for each age- and gender-group adjusting for survey design by 
incorporating survey weights for sample adults. I constructed synthetic cohorts in two time periods 
to examine longitudinal change of BMI: between 1997 to 2007 (period 1), and between 2007 and 
2017 (period 2). Age groups in five-year bands are used to match birth cohorts. For example, 
individuals who are between 20 and 24 years old in 1997 are matched with individuals between 
30 and 34 in 2007. There are a total of 10 cohorts between age 20 and 65 in 1997 who are matched 
to 10 cohorts between age 30 and 75 in 2007. Similarly, 10 cohorts between age 20 and 65 in 2007 
are matched to cohorts between 30 and 75 in 2017. Changes in mean BMI within each period were 
determined for each synthetic cohort and the standard deviation of the difference between the 
means was determined by a z-test in STATA.  
 
Age- and gender-specific change in BMI distribution 
Another important measure in this study is the age- and gender-specific changes across the BMI 
distribution. The sample from 2007 was divided into 9 age-groups with 5-year increments by 
gender and matched with 9 age-groups in 2017 respectively, accounting for the aging effect. For 
example, men who were 30-34 years old in 2007 are matched with men from 40-44 years old in 
2017.  Graphs are presented to illustrate the age- and gender-specific longitudinal changes in the 
BMI distribution over time.  
 
In addition to the BMI distribution, longitudinal changes across the BMI spectrum are also 
investigated. Variations across the BMI spectrum can be telling of whether the weight gain changes 




might experience more weight gain in the next 20 years than those with lower BMI. I categorized 
individuals by gender into 4 age-groups with 10-year increments. These subgroups were further 
divided into 20 quantiles according to their BMI values. For example, a BMI of 25 in 2007 for 20-
29 men was in the 40th quantile. For all these quantiles by age group, I matched them with their 
corresponding age-groups and quantiles in ten years (1997-2007 vs 2007-2017) to study the 
changes. If BMI gain cross the spectrum are the same, then we should observe a horizontal line 
parallel to the x-axis. If we see a line with positive slope, it implies the weight change is higher at 
the upper end of the BMI spectrum.  
 
Impact of socioeconomic or smoking status on BMI change 
Many studies have discovered the weight-related socioeconomic disparities [19-22]. Individuals 
with high SES are less likely to be obese [20,21]. Obesity prevalence among adults with some 
college education is around half the prevalence for those who did not finish high school [23]. Many 
factors contributed to these disparities such as diet, health behaviors and neighborhoods [20,22,24]. 
For example, teenagers with low SES consumed more fast food than their counterparts from high 
SES [20,22]. Neighborhoods with few grocery stores create food desserts and limit access to 
healthy food. Areas where major residents are minority and low-income groups are more likely to 
have food desserts [24].  
 
These studies suggest the significant impact of SES on obesity prevalence and average BMI in the 
population, this study examines whether SES affects BMI changes over time as well. SES status 
is approximated by income where a binary variable is created. Individuals whose household 




Median household income is approximated to be $30,000 in 1997 and $50,000 in both 2007 and 
2017.  
 
Cigarette smoking also affects body weight. Due to the effect of nicotine, smokers have higher 
metabolism rates and depressed diets. The former increases energy consumption and the latter 
reduces food intake, both contributing to lower weight [25-27]. Adult smokers tend to have lower 
BMIs than never-smokers [28-31]. This study examines whether smoking also affects age- and 
gender-specific BMI changes by comparing smokers with never-smokers. I first stratified age- and 
gender-specific groups by smoking behaviors, a categorical variable indicating current smokers or 
never-smokers, and then determined changes in each age-gender and smoking strata.  
 
The analyses in this study were conducted via STATA v14.0 (StataCorp LP, College Station, TX). 
Population representative estimates of weight and BMI were calculated via the svy command in 
STATA that accounts for individual weights and survey design.  
 
1.3 Results 
Age- and gender-specific BMI changes 
Table 1.1 shows the mean BMI by age and gender for matched synthetic cohorts across two periods: 
period I from 1997 to 2007 and period II from 2007 to 2017. And Table 1.2 presents the age-
specific changes in BMI by gender in period I and period II. Among men and women in both 
periods, BMI first increases with respect to age, then decreases for the elderly. This non-linear 
pattern is due to the effect of aging where the elderly experience muscle loss and consequently 




Individuals are expected to experience positive weight gain at the beginning and gradually this 
weight gain diminishes and becomes weight loss. Controlling for age and gender, mean BMI 
increases over time. For example, for women age 30-35, their mean BMI grew from 25.31 in 1997 
to 27.41 in 2007 and 27.78 in 2017.  
 
Table 1.1 Mean BMI by age and gender for matched synthetic cohorts in across two periods. 
Table 1.2 BMI changes by age and gender for matched synthetic cohorts between two periods. 
 
Figure 1.1 shows annualized data for mean BMI change by age over two different periods for men. 
The x-axis is the baseline age cohort, ranging from 20 to 64 years old. The y-axis is the mean BMI 
change annually with a 95% confidence interval. The black open squares are for period I (1997-
2007) and blue solid squares for period II (2007 – 2017). In general, BMI change is age-dependent 
with younger men gaining more BMI than the older ones. The changes in BMI do differ across 
two periods. From 1997 to 2007, men tend to put on more weight over time than their counterparts 
from 2007 to 2017. For example, for men between 20 and 24 in 1997, they gained an average of 
0.26 BMI per year in ten years. But for those between 20 and 24 in 2007, they only gained an 
average of 0.19 BMI per year in ten years. If we assume an average height of 1.78m, this weight 
gain is 0.82 kg in period 1 and only 0.6 kg in period 2.  
 
Figure 1.1 Age-specific increase in mean BMI between 1997-2007 and 2007-2017 for men.  
 
The annualized data for mean BMI change by age over two different periods for women can be 




tend to gain more weight and those in period II gains slightly less weight than their counterpart 
in period I. 
 
Figure 1.2 Age-specific increase in mean BMI between 1997-2007 and 2007-2017 for women. 
 
Age- and sex-specific change in BMI distribution 
Figure 1.3 and 1.4 below illustrate the changes in BMI distribution between 2007 and 2017 for 9 
synthetic age-cohorts by gender. Solid lines represent BMI distributions in 2007 and dashed ones 
are BMI distributions in 2017 for the same age cohort. The x-axis is BMI and y-axis the population 
density. Across all cohorts, the BMI distribution has shifted to the right in ten years and become 
more right skewed. The shift is the greater for younger men and women. The shifts in BMI 
distribution for elder men and women are minor. These findings are consistent with previous 
research where increasing obesity prevalence across age-groups are discovered over time.  
 
Figure 1.3 Change in BMI distribution between 2007 and 2017 by age cohorts for men.  
Figure 1.4. Change in BMI distribution between 2007 and 2017 by age cohorts for women.  
 
Figure 1.5 shows the pattern of BMI change across the BMI spectrum. For each sub-graph, the x-
axis is the baseline BMI value and the y-axis is the annual change in BMI. The black open circles 
represent changes in period I and the blue circles represent changes in period II. In all subgraphs, 
BMI gains do not lie parallel to the x-axis. We observe a growth in BMI when moving to the upper 
end of the BMI spectrum. These patterns indicate differential weight gains where individuals with 




example, from 1997 to 2007, 20-29 men in the 10th percentile gained around 0.03 BMI annually 
while those in the 90th percentile gained 0.015 BMI annually.  
 
Figure 1.5 Change in BMI across the BMI spectrum for men and women over two periods. 
 
Impact of socioeconomic status and smoking behaviors 
SES approximated by household income has a significant effect on age-specific changes among 
men and women. Age-dependent linear regressions for high vs low SES resulted in different slopes 
for men (p=0.099) and women (p = 0.04). For both genders, individuals with low SES experience 
greater variations in BMI gain over time.  
 
Figure 1.6 Age-specific change in BMI for men and women between 2007 and 2017, stratified by 
household income. 
 
Male smokers tend to experience insignificant weight changes as they age. For example, between 
the age of 30 and 64, the mean BMI changes are all insignificant. As a result, male smokers have 
lower BMI than never-smokers with positive weight gains. This pattern is similar for female 
smokers. They also experience insignificant weight changes between the age of 35 and 64, 
except for the period of 45 to 49.  
 
Figure 1.7 Age-specific change in BMI for men and women between 2007 and 2017, stratified by 






This study investigated the age- and gender-specific longitudinal BMI change among US adult 
smokers from 1997 to 2019 with the help of synthetic cohort analysis. There are a few important 
findings. First, BMI change is strongly age-dependent. Younger individuals experience greater 
weight gains. These weight gains gradually diminish over time and after the age of 60 or 70 when 
individuals start to lose weight as a result of aging and muscle loss. Compared with the period 
from 1997 to 2007, annual weight gain has stayed pretty similar except for young males, who 
actually see a slight decrease in weight gain.  
 
In addition to BMI changes over time, I also examined age-specific mean BMI gain across the 
BMI distribution. There exists differential weight gain across the spectrum with greater gains at 
the upper end of the BMI spectrum in both periods.  
 
The age-specific mean BMI gain have not increased from period i to period ii. However, mean 
BMI for each age-cohorts provided in Table 1 suggest otherwise, where there is an increasing BMI 
for the same age-cohort across time. One plausible explanation is that although BMI changes are 
relatively constant, initial BMI of individuals entering adulthood have increased. In this case, we 
would also observe an increasing obesity prevalence across age-cohorts. For example, if males 
entering adulthood in 1997 with a BMI of 20, they are not going to become obese in the next ten 
years with an annual increase of 1 BMI per year. However, with the same BMI growth, another 





The relatively constant BMI gain in adulthood across two periods suggests higher weight gain for 
children or teenagers in the later period. Consistent with this hypothesis, scholars have discovered 
an increasing rate of childhood obesity in many countries [2,33]. Using the National Health and 
Nutrition Examination Survey, Hales et al. reported a youth (2-19) obesity prevalence to be 18.5% 
in 2015, compared with 17.2% in 2013 and a 13.99% in 1999. Childhood or adolescent obesity is 
also closely connected with adulthood obesity. Obese children and teenagers were five times more 
likely to become obese in adulthood than those who were not [34].  This finding is crucial in 
designing public health interventions for obesity. If adult obesity is a result of higher weight when 
entering adulthood, more efforts should be put to reduce weight gain or preventing obesity for 
children and adolescents. 
 
The significant impact of SES on weight gains suggest ongoing inequalities where population with 
lower income suffer from greater weight gains. At the same time, smoking behaviors modify 
weight gains where smokers experience less weight gain. Smokers tend to concentrate among low 
SES population. This relationship between BMI and smoking behaviors via SES further 
complicates the interpretation of population level measures. To some extent, smoking has reduced 
the weight disparity across low and high SES. If all current smokers quit smoking the next day, 
we will see an increase in average BMI due to post-cessation weight increase and also a growth of 
obesity prevalence. The BMI shift will concentrate among minority and lower income groups as 
well. Consequently, if no weight management program is added to smoking cessation intervention, 





There are some limitations to this study. First, smoking behaviors are self-reported data in NHIS 
where measurement errors might occur. And SES in this study is measured as a binary variable 
via median household income. Other alternative measures of SES will be included in the future to 
test the relationship. For example, education attainment and occupations are common measures of 
SES. Another limitation is the differential mortality rate with respect to BMI values. Mean BMI 
and BMI changes could be partly due to selection bias where less healthy individuals experience 
higher mortality rates. For example, extremely low BMI is indicative of severe illness and class 
III obesity (BMI > 40) is associated with elevated mortality rates. In this study, I assume the trend 
of differential mortality rates is the same over 20 years. But with the development of technology, 
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Tables and Figures 
 
Table 1.1 Mean BMI by age and gender for matched synthetic cohorts across two periods. 
 









   2007 
NHIS 
   2017 
NHIS 
   
 Age 
group 
Mean s.d. n Age 
group 
Mean s.d. n Age 
group 
Mean s.d. n 
Men 20-24 25.4 4.31 1128 20-24 26.22 4.88 816 20-24 - - - 
 25-29 26.39 4.77 1533 25-29 27.44 5.1 879 25-29 27.54 5.46 955 
 30-34 26.5 4.63 1763 30-34 27.99 5.76 946 30-34 28.15 5.57 965 
 35-39 27.07 4.67 1797 35-39 28.37 5.26 921 35-39 28.39 5.26 924 
 40-44 27.4 4.68 1684 40-44 28.38 5.08 935 40-44 29.27 5.70 841 
 45-49 27.42 4.7 1427 45-49 28.58 5.03 991 45-49 29.23 5.47 961 
 50-54 27.75 4.64 1175 50-54 28.61 5.55 912 50-54 29.75 5.84 971 
 55-59 27.55 4.68 905 55-59 28.40 5.33 789 55-59 28.99 5 1037 
 60-64 27.22 4.83 841 60-64 28.34 5.5 717 60-64 29.09 5.88 1109 
 65-69 27.13 4.74 778 65-69 27.73 5.69 600 65-69 28.89 6.62 1021 
 70-74 - - - 70-74 27.53 4.89 438 70-74 28.07 5.25 818 
             
Women 20-24 24.33 5.1 1449 20-24 24.46 4.85 941  20-24 - - - 
 25-29 24.79 5.77 1838 25-29 25.81 6.25 986  25-29 27.17 6.39 982 
 30-34 25.31 6.03 2055 30-34 27.41 7.35 1024  30-34 27.78 7.08 1071 
 35-39 25.56 5.76 2226 35-39 27.39 7.56 1091  35-39 28.36 7.03 1046 
 40-44 26.24 5.97 1932 40-44 27.64 7.12 1075  40-44 29.04 7.18 934 
 45-49 26.53 5.79 1692 45-49 27.08 5.95 1122  45-49 28.44 6.43 982 
 50-54 27.11 5.92 1363 50-54 28.02 7.27 1068  50-54 28.48 6.38 1155 
 55-59 27.1 5.65 1106 55-59 28.26 6.47 890  55-59 28.88 7.69 1177 
 60-64 26.89 5.57 968 60-64 28.11 6.48 808  60-64 28.64 7.81 1224 
 65-69 26.4 5.61 1092 65-69 27.93 6.61 680  65-69 28.49 7.74 1216 








































  Period I  Period II 
 Age group Mean s.d. Age group Mean s.d. 
Men 20-24 2.6 0.15 20-24 1.93 0.24 
 25-29 1.98 0.19 25-29 0.95 0.24 
 30-34 1.87 0.18 30-34 1.28 0.26 
 35-39 1.51 0.18 35-39 0.85 0.24 
 40-44 1.21 0.19 40-44 1.38 0.24 
 45-49 0.98 0.21 45-49 0.41 0.21 
 50-54 0.59 0.22 50-54 0.47 0.25 
 55-59 0.18 0.25 55-59 0.49 0.27 
 60-64 0.3 0.26 60-64 -0.27 0.27 
       
Women 20-24 3.08 0.26 20-24 3.32 0.28 
 25-29 2.6 0.26 25-29 2.55 0.3 
 30-34 2.33 0.22 30-34 1.63 0.34 
 35-39 1.51 0.25 35-39 1.05 0.32 
 40-44 1.78 0.26 40-44 0.84 0.3 
 45-49 1.73 0.27 45-49 1.81 0.3 
 50-54 1 0.28 50-54 0.63 0.33 
 55-59 0.83 0.3 55-59 0.22 0.32 





Figure 1.1 Age-specific increase in mean BMI between 1997-2007 and 2007-2017 for men. 
 
 
Note. Black open squares: mean BMI change in period I (1997-2007). Blue filled squares: mean 








Figure 1.2 Age-specific increase in mean BMI between 1997-2007 and 2007-2017 for women. 
 
 
Note. Black open squares: mean BMI change in period I (1997-2007). Blue filled squares: mean 





















Figure 1.3 Change in BMI distribution between 2007 and 2017 by age cohorts for men.  
 
 





















Figure 1.4 Change in BMI distribution between 2007 and 2017 by age cohorts for women.  
 
 






















Figure 1.5 Change in BMI across the BMI spectrum for men and women over two periods. 
 
 
Note. Black open dots: change in BMI in period I (1997-2007). Blue filled dots: change in BMI 




















Figure 1.6 Age-specific change in body mass index for men and women between 2007 and 2017, 




Note. Blue filled squares: low SES with less than median household income; black open squares: 





Figure 1.7 Age-specific change in body mass index for men and women between 2007 and 2017, 










 Comparing Benefits of Quitting vs Harm Due to Post-Cessation Weight Gain: 




Smoking cessation has well-documented health benefits. Studies have found that the all-cause 
mortality rate is about three times among smokers compared to those who have never smoked [1]. 
Despite the health benefits associated with smoking cessation, there is an unintended consequence 
of quitting: post-cessation weight gain. This weight gain can lessen some of the health benefits of 
quitting. For example, post-cessation weight increase contributes to an increased risk of type 2 
diabetes in the short run, hypertension, and a reduced improvement of lung function [2,3]. 
Furthermore, post-cessation weight gain serves as a major deterrent for smokers to quit, especially 
female smokers who are concerned about their body image [4-6]. In a national random-digit dialing 
survey of women smokers, more than 60% described themselves as somewhat concerned about 
post-cessation weight gain. The authors concluded that weight-concerned women will be unlikely 
to seek smoking cessation treatment due to self-image issues [4]. Similarly, in a study done in the 
Czech Republic, around 34% of all patients in a smoking cessation treatment were concerned about 
weight (19.4% for men and 49.7% for women). These weight concerns were associated with delay 





The physiological mechanism that smoking affects body weight is through nicotine. Nicotine is 
known to increase metabolism and decrease body weight. Body weight is determined by the 
difference between calorie intake from food and daily energy expenditure, which can be further 
divided into subcategories of basic metabolism rate, physical activity and thermic effects of food 
[7,8]. Nicotine reduces body weight by increasing basic metabolism rate as well as suppressing 
appetite that results in less food intake [9,10]. Once smokers stop smoking, their metabolism rates 
slow down and their appetites increase, leading to weight gain.  
 
While most people gain weight after smoking cessation, there is considerable variance in the 
amount of weight gain. A meta-analysis done by Aubin et al. in 2012 found, from 62 studies, the 
mean weight gain was 4.67 kg (10.3 lbs) at 12 months after quitting. But around 13% of quitters 
gained more than 10 kg (22 lbs) [11]. Another meta-analysis done by Tian et al. in 2015 identified 
35 cohort studies, including 63,403 quitters and 388,432 smokers. The mean weight gain was 4.10 
kg (9 lbs) among quitters, compared with 1.5 kg (3.3 lbs) for continuing smokers [12]. 
 
However, most of these studies reported in the systematic reviews only followed individuals up to 
12 months after cessation. Only a few studies reported weight gain over the long term in 
biochemically confirmed abstainers. The Lung Health Study found quitters gained 8.2 kg (18.1 
lbs) over 5 years, versus the 1.6 kg (3.5 lbs) gained by smokers [13]. Lycett et al. followed a total 
of 1686 participants for 8 years in 19 general practices in Oxfordshire, UK. Abstainers gained 8.79 
kg (19.4 lbs) where smokers gained 2.24 kg (4.9 lbs) on average at the end of 8 years [14]. Since 
majority of the literature measured only weight changes in smokers vs quitters as point estimates, 




investigated weight trajectory is from Williamson et al. using the First National Health and 
Nutrition Examination Survey (NHANES I, 1971 to 1975). They found that smokers gain on 
average, 4.5 kg (9.9 lbs), within 6-12 months after quitting. And their weight returned to the same 
weight-age trajectory as that observed in never smokers in around 10 years [15]. However, a recent 
paper using the Framingham Heart Study showed that post-cessation weight gain is still detectable 
after 20 years of quitting [16]. 
 
Researchers have discovered that the benefits of smoking cessation also differ depending on quit-
age, aka at what age smokers quit smoking [1,17]. For example, adults who quit smoking between 
25 and 34 gain around 10 years of life expectancy while those who quit between 45 and 54 only 
gain 6 years on average [1]. Based on a study of women in the UK, those who quit before age 40 
years avoided more than 90% of the excess mortality caused by continuing smoking [17].  
 
Despite the health gains from smoking cessation, post-cessation weight gain can attenuate the 
health benefits of quitting. Since the benefits of smoking cessation decrease with age-at-quit (quit-
age), it is conceivable that the benefits obtained by quitting at a later age could be completely offset 
by the harm associated with the weight gain. In this study, I estimate the break-even weight gain, 
i.e. the minimum weight individuals could gain to completely offset the benefits of smoking 
cessation, adjusting for age, gender, race and initial BMI. I also look for crucial factors that affect 
the break-even weight gain, such as quit-age, gender and initial BMI. High risk groups, those who 
are likely to put on post-cessation weight that is greater than break-even weight gain, are identified. 




and could be used to parameterize simulation models aimed to investigate the impact of combined 
policies to address smoking and obesity simultaneously.  
 
This paper is the first study to define and examine the notion of break-even weight gain. It 
contributes to the ongoing debate on how weight gain after smoking cessation attenuates the health 
benefits of quitting. It also fills the gap in the literature by directly comparing the benefits of 
quitting with the harm due to post-cessation weight increase, adjusting for demographic 
characteristics. It is crucial to study break-even weight gain for smokers to ensure that they receive 
positive net health benefits.  
 
2.2 Methods 
This study is comprised of two major components: 1. Estimating all-cause mortality as a function 
of BMI and smoking status; 2. Estimating baseline lifetime weight trajectories. First, I calculated 
the relative risk (RR) for all combinations of BMI and smoking status adjusting for demographic 
variables. Then I estimated the all-cause mortality rate for normal-weight never-smokers 
controlling for age, gender and race. Lastly, the baseline lifetime weight trajectory is calculated 
for current, former and never smokers adjusting for age, gender, race, previous-year BMI, and 
socioeconomic status (SES). I implemented two forms of post-cessation weight gain for quitters: 
permanent weight-gain (an instantaneous permanent weight gain following smoking cessation) 
and diminishing weight-gain (an initial weight gain following smoking cessation which declines 
over time). Combining these components with discounted life-years saved due to smoking 
cessation from the survival curve, I computed the break-even weight gain for smokers given gender, 





Relative risk of BMI and smoking status 
An article published in the Lancet by the Global BMI Mortality Collaboration assessed the impact 
of BMI on all-cause mortality using 239 prospective studies in four continents. Using a total of 
10,625,411 participants in Asia, Australia and New Zealand, Europe, and North America, the 
authors concluded that all-cause mortality was minimal at BMI from 22.5 to 25, and mortality 
increased approximately log-linearly with BMI after 25 [18]. Using their hazard ratio (HR) 
estimates for various BMI levels controlling for gender, I calculated the impact of post-cessation 
weight gain for quitters. For BMI over 25, the mortality rate increases log-linearly, adjusting for 
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To calculate the RR of mortality adjusting for smoking behaviors, I employed the all-cause 
mortality RR calculated in Mendez and Warner’s work [19]. They analyzed the Cancer Prevention 
Study II (CPS II) data to derive the RR for men and women current and former smokers as a 
function of age and, for former smokers, years quit via logistic regressions. Their study showed 
that the benefits of smoking cessation vary by age and years quit. The later one quits smoking, the 
less benefits he/she would recover. The equation they used is shown below where i stands for 




𝑙𝑜𝑔(𝑅𝑅𝑠𝑚𝑜𝑘𝑖𝑛𝑔)  =  𝛼𝑖,𝑗 + 𝛽𝑖,𝑗 × 𝑎𝑔𝑒 + 𝛾𝑖,𝑗  × 𝑦𝑒𝑎𝑟𝑞𝑢𝑖𝑡 
All-cause mortality rate 
Another important piece is the all-cause mortality rate for the base group. Given the all-cause 
mortality RR of smoking and BMI, I need to calculate the baseline mortality risk to recover 
mortality rates for all groups. In Mendez and Warner’s work, the baseline risk used is the mortality 
rate for never-smokers [19]. For obesity related RR, the HR is 1 for normal weight individuals 
with a BMI between 18.5 and 25. Based on these references, the control group in this study are the 
normal-weight never-smokers, adjusting for age, gender and race.   
 
From a recent publication of the National Vital Statistics Reports, I obtained annual mortality rates 
in the US by race and gender in 2016 [20]. I then combined the mortality rates with a group 
prevalence calculated from the National Health Interview Survey (NHIS) in 2016, adjusting for 
smoking and obesity status.  I divided the NHIS sample into 5-year age groups from 40 to 85 and 
assumed the population prevalence remain the same in these five years. Table 2.1 presents the 
group prevalence adjusted for smoking and weight statuses by gender, race and age. Individuals 
are also categorized into one of the nine smoking- and obesity-status groups by gender. There are 
three groups based on smoking status: 1. Current smoker; 2. Former smoker; 3. Never smoker. 
And three groups based on obesity status: 1. Overweight (BMI > 25); 2. Normal weight 
(18.5<BMI< 25); 3. Underweight (BMI< 18.5). Together with the RR of smoking and BMI, I 
estimated the annual mortality rates in 2016 for all individuals over 40 years old, by one-year 
increment and adjusted for gender and race [18, 21]. A more detailed description of RRs 
implemented in the model can be found in Table 2.2. The calculations are conducted using the 










Here MR is the population level mortality rate in 2016 and n stands for the race- and gender-group. 
There are four race- and gender-groups: white male; white female, black male and black female. 𝑖 
is smoking status and 𝑗 is obesity status. There are three possible status for smoking and obesity, 
respectively. 𝑅𝑅𝑖,𝑗  is the relative risk of mortality for a race- and gender-group with smoking status 
i and obesity status j. These relative risks are derived from previous literature. Then I have 𝑊𝑖,𝑗,𝑛 
to be the group specific weight in the population for individuals with smoking status i and obesity 
status j. Finally, 𝑏𝑛 stands for the base group mortality rate for a specific race and gender-group, 
which is the value I want to calculate.  
 
Table 2.1. Group Prevalence adjusted for smoking and weight statuses by gender, race and age. 
Table 2.2. Relative risk (RR) adjusted for smoking and weight statuses by gender. 
 
Table 2.3 below illustrates the all-cause mortality rate estimated for all four race and gender-groups 
from age 40 till 100, where I assumed the maximum life-span is 100 years. I counted the impact 
of smoking and obesity on all-cause mortality as additive per the results from Mehta and Preston’s 
work [22].  
 
Table 2.3. Age-specific annual mortality rates for normal-weight never-smokers by gender and 
race. 
 
Lifetime weight trajectory  
The lifetime weight trajectories for current and never smokers are calculated, adjusting for age, 




Study (HRS) from 1992 to 2014. HRS is a longitudinal panel study that surveys a representative 
sample of the US population every two years. It is conducted by the Survey Research Center at the 
University of Michigan and sponsored by the National Institute on Aging. At the baseline in 1992, 
a total of 12,652 individuals from 7,702 households participated. My sample includes only this 
initial HRS cohort who joined the study in 1992. A few exclusion criteria are applied to obtain my 
final sample. The flowchart below in Figure 2.1 illustrates the process. I tracked all twelve waves 
of data (1992 till 2014) to investigate how BMI changes with respect to smoking behavior and 
demographic variables over time.  
 
Figure 2.1 Flowchart for selecting eligible participants in the final sample from the Health and 
Retirement Study. 
 
My final sample includes 9,606 unique individuals and 69,745 person-year observations. At 
baseline, the average age is 55.22 years, 43.04% of participants are male, 80.23% of them are 
white and the average BMI is 26.99. The obesity rate is 22.93%, 81% are married and around 70% 
have degrees of high school or above. See Table 2.4 for more details. This sample is referred to as 
Model I. I also included two other samples with alternative exclusion criteria for robustness check. 
Compared with exclusion criteria in Model I, Model II kept observations with inconsistent year-
quit information while Model III kept observations who passed away within five years of the 
survey or experienced rapid weight changes.  
 
To estimate the lifetime weight trajectory of individuals adjusting for smoking behaviors and 
demographic information, I ran multiple linear regressions to predict the percentage change of 




14.0 (StataCorp LP, College Station, TX) to conduct this analysis. My dependent variable is the 
percentage change of BMI between any two consecutive surveys and my independent variables 
include age, gender, race, SES, and BMI from previous survey. The regression was conducted 
separately for current and never smokers. Here current smokers are defined as those who report to 
have ever smoked cigarettes and are currently consuming cigarettes. Never-smokers are those who 
report to have never smoked cigarettes and are not currently smoking. Regression results for Model 
I, Model II and Model III can be found in Table 2.5. 
 
Table 2.4 Baseline characteristics of the sample population, Health and Retirement Study 1992. 
Table 2.5 Regression results for change in BMI (%) under Model I, Model II and Model III. 
 
Weight-gain mechanism  
I implemented two forms of post-cessation weight gain for quitters: permanent weight-gain vs 
diminishing weight-gain. While many studies have found a permanent weight gain of quitters 
compared to smokers over an extended period [13,14], a few also found that quitters initially gain 
weight, but over time their weight trajectory approaches the same age-weight trajectory of never-
smokers [8,15]. Permanent weight-gain is an instantaneous permanent weight gain following 
smoking cessation compared to the age-weight trajectory of continuing smokers with the same 
initial BMI. The weight difference will remain the same over time. Diminishing weight-gain 
involves an initial weight gain following smoking cessation and the weight trajectory approaches 
those of never-smokers in ten years.  
 
Figure 2.2 provides an example to show how life-time BMI trajectories change with respect to 




either a smoker or a never-smoker. If he was a smoker, he could either quit and experience post-
cessation weight increase at age 51, or he could continue smoking. If he continues smoking, then 
his BMI is going to follow the blue curve for current smoker. If he quits smoking, he either 
experiences a permanent post-cessation weight gain (grey curve) or a diminishing weight increase 
(yellow curve). He could also be a never-smoker with a life-time BMI trajectory shown by the 
orange curve. The BMI trajectory for former smoker with diminishing weight-gain gradually 
approaches the trajectory for never smoker. The two curves overlap after age 60 (yellow and 
orange).    
 
Figure 2.2 Simulated life-time BMI trajectory for a white male with an initial BMI of 25 at age 
50, assuming different smoking behaviors. 
 
Break-even weight gain 
Employing RRs for smoking and BMI, all-cause mortality for non-obese never-smokers, and the 
survival curve until age 100, I calculated the break-even weight gain controlling for age, gender 
and initial BMI. Here initial BMI is the BMI of the quitter at the time when he/she quit smoking. 
The survival analysis is implemented using Python.   
 
I derived the break-even weight gain adjusting for age and gender with the help of the survival 
curve. By going over a possible range of weight gains, I looked for the break-even weight gain 
that completely offsets the discounted benefits gained from smoking cessation examining the 
discounted total life-years saved till age 100. Discounting rate is set at 3% in the main results and 
sensitivity analyses are conducted for discounting at1% and 7% [23]. I programmed in Python to 




Figure 2.3 below is an example of how survival analysis is carried out to calculate the break-even 
weight gain. Each data point represents the cumulative survival probability for the individual at a 
certain age. Current smoker (blue) in Figure 3 continues smoking from age 50 till 100. Former 
smoker I (orange) gave up smoking at age 50 and gained no post-cessation weight while former 
smoker II (grey) quit smoking also at age 50 but gained a significant amount of weight. I compared 
whether the area under the survival curve for former smoker is greater than the area under the 
curve for current smoker, aka a comparison of mean survival time. Since the survival curve for 
current smoker (blue) lies below the curve for former smoker I (orange), smoking cessation in this 
case increases mean survival time. However, the survival curve for current smoker (blue) lies 
above the curve for former smoker II (grey), implying smoking cessation in this context decreases 
the survival time. As a result, the break-even weight gain lies somewhere between the post-
cessation weight gain for former smoker I and former smoker II.  
 
Figure 2.3 Survival curves for current smoker vs former smoker I vs former smoker II from age 
50 to 100. 
  
2.3 Results 
The average break-even weight gain for individuals with high SES under permanent weight-gain 
are shown in Figure 2.4.  Since there is not much variation in break-even weight gain across initial 
BMI, Figure 4 presents the average break-even weight gain of initial BMI from 25 to 40. A more 
detailed description of break-even weight gain by initial BMI can be found in Appendix 2.A. At 
quit-age of 50, the break-even weight gain for white males is around 9.7 units of BMI, 11.6 units 
for white females, 9.9 units for black males and 11.4 units for black females. If they quit at 80, the 
break-even weight gain decreases to 1.41 units, 1.57 units, 1.42 units and 1.59 units, respectively. 




quit-age. Break-even weight gain decreases significantly by quit-age but does not vary much by 
race.  
Figure 2.4 Average break-even weight gain (BMI) by gender, race and quit-age under 
permanent weight gain. 
 
Figure 2.5 displays the break-even weight gain for all race and gender-groups under diminishing 
weight-gain at quit-age 80 with varying initial BMI. The break-even weight gain for smokers who 
quit before age 80 is more than 50 lbs on average; I do not consider that a 50 lbs post-cessation 
weight gain is highly like and thus omit it in the exhibits. I find that for all race and gender-groups, 
as initial BMI increases, break-even weight gain decreases. Break-even weight gain decreases 
from 30.5 lbs at 25 BMI to 12.3 lbs at 40 BMI for white males of average height, 27.6 to 12.1 lbs 
for white females, 28.8 to 9.4 lbs for black males and 28.4 to 9.5 lbs for black females. I used 1.76 
m (5 feet 8) as the male average height and 1.63 m (5 feet 3) as the female average height. Initial 
BMI is negatively correlated with break-even weight gain for all gender and race-groups 
controlling for quit-age. Consistent with findings under permanent weight gain, the later one quits 
smoking, the lower the break-even weight gain is.  
 
Figure 2.5 Break-even weight gain (lbs) at quit-age 80 by gender, race and initial BMI under 
diminishing weight-gain. 
 
Figure 2.6A shows the total life-years saved for white males with an initial BMI of 25 while Figure 
2.6B presents the one for white males with an initial BMI of 40 across various quit-ages. In Figure 
2.6A, a white male quits at 50 with no post-cessation weight gain acquires around 4.3 life-years 
and only 3.6 life-years if he experiences an average post-cessation weight gain of 10.3 lbs (a 16.28% 




gain and 0.2 life-years with average post-cessation weight gain (a 50% reduction). Post-cessation 
weight gain reduces the life-years saved from smoking cessation. Similar patterns hold with an 
initial BMI of 40 in Figure 2.6B.  
 
Figure 2.6 Total life-years saved for white males with no post-cessation weight gain vs average 
post-cessation weight gain with known initial BMI at age 50. 
 
In addition, I derived life-years saved at the population level if smokers gain zero weight post-
cessation versus gaining an average post-cessation weight of 10.3 lbs. Based on the nationally 
representative smoker sample in NHIS 2017, I estimated 29,186,912 smokers with survey 
weighting. I excluded observations with missing data and who were pregnant at the time of the 
survey. I then modified the original Python program to incorporate individual level weight gains 
to calculate life-years saved for smokers. If all of these smokers quit the next year and experience 
zero post-cessation weight gain, total life-years saved is estimated to be 150,051,770, that is around 
5.14 life-years per smoker. If they experience an average post-cessation weight gain, then total 
life-years saved will drop by 18,661,067 in total, aka a 0.64 life-year difference per capita.  
The results above are for individuals with high SES. I also calculated the break-even weight gain 
for smokers with low SES under permanent and diminishing weight gain (See Appendix 2.B). In 
general, the break-even weight gain for individuals with low SES is similar to the ones with high 
SES. Break-even weight gain calculated using alternative forms of lifetime weight trajectory 
(Model II and Model III) can also be found in Appendix 2.C. The results are similar to the ones 






2.4 Sensitivity Analysis  
For sensitivity analysis, I first checked the results using discounting rates of 1% and 7%, 
respectively [23]. Then I reexamined the model by replacing the 2016 mortality rates for normal-
weight never-smokers with mortality rates from other years. Sensitivity analysis yielded similar 
results as main findings, indicating that the results are robust.  More details can be found in 
Appendix 2.D. 
 
2.5 Discussion  
This study offers important findings. First, a potentially attainable break-even weight gain does 
exist for certain combinations of quit-age and BMI. Smoking cessation is beneficial at any age, 
but post-cessation weight gain could significantly reduce these health benefits.  
 
Second, the break-even weight gain decreases with quit-age. There exists a cut-off age where 
smoking cessation might lead to more harm than good to smokers. Quit-age is the most important 
factor affecting the tradeoff between cessation benefits and harm from post-cessation weight gain. 
Given that quitters gain an average of 10.3 lbs and more than 10% of them gain over 22 lbs [11], 
a smoker who quits at 80 will have a higher chance to receive negative health benefits from quitting.   
Currently, the health message provided to smokers is that it is never too late to quit, without 
addressing the weight concern that many have. The findings show the perils of addressing obesity 
and smoking independently. Smokers should couple smoking cessation with weight management 
programs, especially those who might experience a substantial weight gain post-cessation compare 





Results in this study agree with previous findings in general. For most smokers, quitting brings 
positive net health benefits despite post-cessation weight gain. However, the low break-even 
weight gain for some subgroups suggests a possibility of negative net health benefits. It is crucial 
to distinguish smokers who might gain a substantial amount of weight from quitting. A few high-
risk groups can be identified based on our study and previous research. The first high-risk group 
consists of heavy smokers. Studies have shown a positive relationship between post-cessation 
weight gain and smoking intensity [24]. Heavy smokers (>24 cigarettes daily) tend to put on 
significantly more weight than either continuing smokers or former light smokers (<15 cigarettes 
daily) [24]. Another high-risk group are obese smokers. Since higher initial BMI is associated with 
lower break-even weight gain, obese smokers are likely to gain weight that is above the threshold. 
Individuals with low SES are more likely to be heavy smokers and suffer from obesity [25,26]. 
They tend to smoke cigarettes more and for a longer duration [25]. For example, individuals who 
enroll in Medicaid are about twice as likely as the general population to smoke [27].  Smokers 
with low SES also have a lower cessation rate on average [28].  Smoking cessation with no weight 
management for groups with low SES is likely to exacerbate existing health disparities.  
 
Another take-away is the importance to study long-term post-cessation weight gain. The two 
weight gain mechanisms implemented lead to different values of break-even weight gain. If post-
cessation weight gain remains permanent, the break-even weight gain will be lower across all 
gender and race-groups. We need more research to determine whether post-cessation weight gain 





One key policy implication is to search for effective weight management programs to help smokers 
deal with post-cessation weight gain. Existing approaches, such as antismoking medications or 
weight-related behavioral interventions, have not shown much success, especially in the long run 
[29-31]. One alternative, electronic cigarette has revealed some promising results. Post-cessation 
weight gain is significantly decreased when smokers quit or reduced substantially their cigarette 
consumption by switching to electronic cigarettes [32]. More research is needed to provide further 
evidence.  
 
There are some limitations of this study. First, the impact of SES on break-even weight gain is 
underestimated since it is only included in the calculations for lifetime weight trajectory, but not 
for mortality rates or RRs. Findings in this study show that break-even weight gain does not vary 
much across SES, but more research is needed to explore this topic. Another limitation is the lack 
of information on age-specific post-cessation weight gain. Smokers usually quit in their late 40s 
or early 50s [33]. Future research is needed to investigate the age-specific post-cessation weight 
gain to derive more accurate results. For the population level estimation of life-years saved, I 
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Tables and Figures 
 
































     White Male     
40-44 0.17 0 0.04 0.4 0.001 0.14 0.21 0 0.04 
45-49 0.12 0.001 0.04 0.48 0.008 0.1 0.2 0 0.04 
50-54 0.15 0.004 0.07 0.46 0 0.09 0.2 0 0.04 
55-59 0.14 0.004 0.07 0.399 0.0002 0.08 0.29 0 0.04 
60-64 0.11 0.0005 0.06 0.38 0 0.08 0.31 0.002 0.06 
65-69 0.09 0.0003 0.04 0.32 0 0.08 0.41 0.002 0.07 
70-74 0.06 0.002 0.03 0.28 0 0.07 0.45 0 0.1 
75-79 0.06 0 0.04 0.26 0 0.1 0.39 0.002 0.14 
80-84 0.03 0.001 0.006 0.3 0.003 0.13 0.38 0 0.14 
85+ 0.003 0.0007 0.02 0.25 0.002 0.21 0.31 0.02 0.199 
 White Female 
45-49 0.11 0.01 0.05 0.4 0.006 0.24 0.12 0.006 0.06 
50-54 0.12 0.004 0.06 0.33 0.008 0.26 0.15 0.002 0.06 
55-59 0.13 0.005 0.07 0.37 0.005 0.2 0.16 0.003 0.06 
60-64 0.1 0.003 0.07 0.37 0.005 0.19 0.18 0.003 0.08 
65-69 0.09 0.008 0.05 0.38 0.008 0.22 0.16 0.003 0.08 
70-74 0.06 0.008 0.05 0.39 0.008 0.18 0.21 0.002 0.09 
75-79 0.04 0.008 0.04 0.38 0.005 0.18 0.23 0.004 0.11 
80-84 0.02 0.003 0.03 0.37 0.02 0.2 0.21 0.008 0.15 
85+ 0.01 0 0.02 0.37 0.03 0.23 0.2 0.009 0.13 
 Black Male 
45-49 0.15 0 0.07 0.49 0 0.15 0.1 0 0.05 
50-54 0.24 0 0.02 0.52 0 0.07 0.13 0 0.019 
55-59 0.12 0 0.1 0.43 0.02 0.14 0.2 0 0.004 
60-64 0.17 0 0.08 0.46 0 0.099 0.19 0.002 0.01 
65-69 0.12 0 0.11 0.43 0 0.13 0.18 0 0.03 
70-74 0.1 0.007 0.12 0.24 0.01 0.08 0.35 0 0.09 
75-79 0.03 0.03 0.08 0.28 0 0.06 0.42 0 0.1 
80-84 0.05 0.11 0.12 0.23 0 0.15 0.25 0 0.11 
85+ 0 0 0 0.39 0 0.18 0.2 0 0.23 
 Black Female 
45-49 0.13 0 0.03 0.54 0 0.26 0.04 0.004 0.002 
50-54 0.12 0.01 0.02 0.58 0 0.15 0.11 0 0.007 
55-59 0.13 0 0.04 0.58 0.004 0.12 0.12 0 0.006 
60-64 0.13 0.007 0.03 0.51 0.004 0.12 0.19 0.001 0.01 
65-69 0.08 0 0.1 0.49 0 0.11 0.16 0 0.06 
70-74 0.11 0 0.04 0.53 0.005 0.11 0.14 0 0.05 
75-79 0.06 0 0.03 0.5 0 0.14 0.24 0 0.03 
80-84 0.04 0 0.009 0.5 0 0.15 0.22 0 0.08 
85+ 0.01 0 0 0.45 0.07 0.06 0.2 0 0.2 
There are total of four race-gender groups: white male, white female, black male and black female. Within each 
race-gender group, there are three possible smoking status (smoker, never-smoker and former smoker) and three 




















For both male and female, there are three possible smoking status (smoker, never-smoker and former smoker) and 
































Relative Risk (RR) Male Female 
Overweight Smoker 4.025 3.48 
Underweight Smoker 3.93 3.25 
Normal-weight Smoker 2.8 2.76 
Overweight Never-Smoker 2.225 1.72 
Underweight Never-Smoker 2.13 1.49 
Normal-weight Never-Smoker 1 1 
Overweight Former Smoker 2.695 2.17 
Underweight Former Smoker 2.6 1.94 
Normal-weight Former 





Table 2.3. Age-specific annual mortality rates for normal-weight never-smokers by gender and 
race.  







































40-44 0.12 0.10 0.18 0.14 
45-49 0.16 0.14 0.22 0.19 
50-54 0.25 0.20 0.36 0.30 
55-59 0.36 0.30 0.53 0.43 
60-64 0.53 0.43 0.86 0.62 
65-69 0.73 0.63 1.12 0.86 
70-74 1.13 1.05 1.57 1.28 
75-79 1.86 1.79 2.20 1.99 
80-84 3.22 3.19 4.08 3.29 




Table 2.4 Baseline characteristics of the sample population, Health and Retirement Study 1992. 
 
Characteristics N = 8,958 
Age (years) 55.22 ± 5.55 
Male (%)  43.03 
White Race (%) 80.23 
Weight (kg) 77.62 ± 16.62 
Body Mass Index (BMI)  26.99 ± 5.03 
      Normal Weight (BMI < 25 𝑘𝑔/𝑚2) 36.68 
      Overweight (25 𝑘𝑔/𝑚2 ≤ BMI < 30 𝑘𝑔/𝑚2) 40.39 
      Obese (BMI  30 𝑘𝑔/𝑚2) 22.93 
Height (m) 1.69 ± 0.099 
Smoking status (%)  
      Current Smoker  30.53 
      Former Smoker  25.11 
      Never Smoker  44.36 
Marital Status (%)  
      Married/Partnered 81.16 
      Single  2.88 
      Divorced/Widowed  15.95 
Education (%)   
      Less than High School 30.22 
      High School Graduate 33.05 
      Some College 19.41 




























































































































































13,593 individuals enrolled in 1992 
1 did not have birth information 
1,266 had inconsistent information 
on quit year. See Appendix X for 
more information 
298 former smokers did not report 
quit year 
1,050 did not report BMI in Wave 1 
10,978 individuals,                         
expand to 131,736 person-year 
observations 
 
55,557 experienced more than 30% 
of weight change between any two 
consecutive waves of interview 
76,179 person-year observations 
 
6,252 passed away within 5 years of 
the last survey 
69,927 person-year observations 
182 did not report accurate smoking 
cessation year 
9,606 eligible individuals with 





Figure 2.2 Simulated life-time BMI trajectory for a white male with an initial BMI of 25 at age 
50, assuming different smoking behaviors. 
 
 
Note. Blue curve = current smoker; orange curve = never smoker; grey curve = former smoker 
with permanent weight gain post cessation; yellow curve = former smoker with diminishing 
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Figure 2.3 Survival curves for current smoker vs former smoker I vs former smoker II from age 
50 to 100. 
 
 
Note. Blue curve = current smokers; orange curve = former smoker I with no post-cessation 
























































Figure 2.4 Average break-even weight gain (BMI) by gender, race and quit-age under permanent 
weight gain.  
 
 
Note. Blue column = white males; orange column = black males; grey column = white females; 























































Note. Blue curve = white males; orange curve = white females; grey curve = black males; 











































Break-Even Weight Gain (lbs) at Quit-Age 80 by Gender, Race and 
Initial BMI





Figure 2.6 Total life-years saved for white males with no post-cessation weight gain vs average 
post-cessation weight gain with known initial BMI at age 50. 
 
 
Note. Dark orange bar = white males with an initial BMI of 25 at age 50 and no weight gain 
after quitting; light orange bar = white males with an initial BMI of 25 at age 50 and a post-
cessation weight gain of 10.3 lbs.  
 
 











Total Life-Years Saved for White Males with 25 BMI at Age 50 with No 








Note. Dark blue bar = white males with an initial BMI of 40 at age 50 and no weight gain after 
quitting; light blue bar = white males with an initial BMI of 40 at age 50 and a post-cessation 




























Total Life-Years Saved for White Males with 40 BMI at Age 50 with No 








Appendix 2.A Break-even weight gain in BMI units by initial BMI, quit-age, race and 
gender under permanent weight gain with high SES.  
 
Table 2.A.1 Break-even weight gain in BMI units for males with high SES under permanent 
weight gain.  
  
White Male Black Male 
Initial BMI/ Quit-Age 50 60 70 80 50 60 70 80 
25 10.88 6.31 3.69 2.38 10.12 6.43 4.18 2.62 
26 10.88 6.25 3.42 1.87 10.08 6.31 3.80 2.06 
27 10.87 6.21 3.30 1.62 10.05 6.23 3.61 1.78 
28 10.86 6.18 3.23 1.49 10.03 6.16 3.48 1.61 
29 10.86 6.15 3.17 1.41 10.01 6.12 3.39 1.51 
30 10.86 6.13 3.14 1.36 10.00 6.08 3.33 1.44 
31 10.86 6.11 3.11 1.32 9.98 6.05 3.27 1.39 
32 10.86 6.10 3.08 1.29 9.97 6.02 3.23 1.35 
33 10.86 6.09 3.06 1.27 9.96 5.99 3.20 1.32 
34 10.86 6.07 3.04 1.25 9.95 5.97 3.17 1.30 
35 10.86 6.06 3.03 1.23 9.94 5.95 3.14 1.28 
36 10.86 6.05 3.01 1.22 9.93 5.94 3.12 1.26 
37 10.86 6.04 3.00 1.21 9.92 5.92 3.10 1.25 
38 10.86 6.03 2.99 1.20 9.92 5.91 3.08 1.24 
39 10.86 6.03 2.98 1.19 9.91 5.89 3.07 1.23 

















Table 2.A.2 Break-even weight gain in BMI units for females with high SES under permanent 
weight gain.  
 
 White Female Black Female 
Initial BMI/ Quit-Age 50 60 70 80 50 60 70 80 
25 12.98 7.93 4.21 2.23 12.65 7.96 4.68 2.55 
26 12.98 7.87 3.99 1.75 12.61 7.83 4.31 2.00 
27 12.97 7.84 3.89 1.57 12.58 7.75 4.13 1.74 
28 12.97 7.82 3.83 1.48 12.56 7.69 4.01 1.60 
29 12.97 7.80 3.79 1.43 12.54 7.64 3.93 1.51 
30 12.96 7.78 3.76 1.40 12.53 7.60 3.87 1.45 
31 12.96 7.77 3.74 1.38 12.51 7.58 3.83 1.42 
32 12.96 7.77 3.72 1.37 12.50 7.55 3.80 1.39 
33 12.97 7.76 3.71 1.36 12.50 7.53 3.77 1.37 
34 12.97 7.75 3.70 1.36 12.49 7.52 3.75 1.36 
35 12.97 7.75 3.69 1.35 12.48 7.50 3.73 1.35 
36 12.97 7.74 3.68 1.35 12.48 7.49 3.72 1.34 
37 12.97 7.74 3.68 1.34 12.47 7.48 3.70 1.33 
38 12.97 7.74 3.67 1.34 12.47 7.47 3.69 1.33 
39 12.97 7.73 3.66 1.34 12.47 7.47 3.68 1.32 


























Appendix 2.B Break-even weight gain in BMI units for smokers with low SES under 
permanent weight gain. 
 
Table 2.B.1 Break-even weight gain in BMI units for males with low SES under permanent 
weight gain.  
 
 White Male Black Male 
Initial BMI/Quit-Age 50 60 70 80 50 60 70 80 
25 10.1 6.6 4.0 2.3 10.1 6.7 4.3 2.5 
26 10.1 6.5 3.7 1.8 10.0 6.5 3.9 1.9 
27 10.1 6.4 3.6 1.6 10.0 6.4 3.6 1.6 
28 10.0 6.4 3.5 1.5 9.9 6.3 3.5 1.5 
29 10.0 6.4 3.4 1.4 9.9 6.3 3.4 1.4 
30 10.0 6.3 3.4 1.4 9.9 6.3 3.4 1.4 
31 10.0 6.3 3.3 1.3 9.9 6.2 3.3 1.3 
32 10.0 6.3 3.3 1.3 9.9 6.2 3.3 1.3 
33 10.0 6.3 3.3 1.3 9.9 6.2 3.3 1.3 
34 10.0 6.3 3.3 1.3 9.9 6.1 3.2 1.3 
35 10.0 6.3 3.3 1.3 9.8 6.1 3.2 1.3 
36 10.0 6.3 3.3 1.3 9.8 6.1 3.2 1.2 
37 10.0 6.3 3.3 1.3 9.8 6.1 3.2 1.2 
38 10.0 6.3 3.2 1.2 9.8 6.1 3.2 1.2 
39 10.0 6.2 3.2 1.2 9.8 6.1 3.2 1.2 























Table 2.B.2 Break-even weight gain in BMI units for females with low SES under permanent 
weight gain. 
 
 White Female Black Female 
Initial BMI/Quit-Age 50 60 70 80 50 60 70 80 
25 11.6 7.7 4.6 2.4 11.5 7.9 4.9 2.6 
26 11.6 7.6 4.3 1.9 11.5 7.7 4.5 2.0 
27 11.6 7.6 4.2 1.7 11.5 7.6 4.3 1.8 
28 11.6 7.5 4.1 1.6 11.4 7.6 4.1 1.6 
29 11.6 7.5 4.0 1.5 11.4 7.5 4.1 1.6 
30 11.6 7.5 4.0 1.5 11.4 7.5 4.0 1.5 
31 11.6 7.5 4.0 1.5 11.4 7.5 4.0 1.5 
32 11.6 7.5 4.0 1.5 11.4 7.4 3.9 1.5 
33 11.6 7.5 4.0 1.5 11.3 7.4 3.9 1.5 
34 11.6 7.5 3.9 1.5 11.3 7.4 3.9 1.4 
35 11.6 7.4 3.9 1.5 11.3 7.4 3.9 1.4 
36 11.6 7.4 3.9 1.5 11.3 7.4 3.9 1.4 
37 11.6 7.4 3.9 1.5 11.3 7.4 3.9 1.4 
38 11.6 7.4 3.9 1.5 11.3 7.4 3.8 1.4 
39 11.6 7.4 3.9 1.5 11.3 7.3 3.8 1.4 



























Appendix 2.C Break-even weight gain in BMI units for smokers under diminishing weight 
gain. 
 
Table 2.C.1Break-even weight gain in BMI units for smokers with low SES under diminishing 
weight gain. 
 
 White Male White Female Black Male Black Female 
Initial BMI/Quit-Age 70 80 70 80 70 80 70 80 
25 14.42 4.30 17.52 4.51 12.18 4.34 16.36 4.55 
26 13.87 3.48 16.79 3.69 11.40 3.43 15.37 3.63 
27 13.49 3.20 16.30 3.42 10.94 3.04 14.72 3.24 
28 13.14 3.08 15.90 3.27 10.57 2.84 14.20 3.03 
29 12.83 2.97 15.56 3.16 10.23 2.69 13.79 2.86 
30 12.53 2.87 15.24 3.05 9.93 2.55 13.42 2.71 
31 12.24 2.77 14.95 2.97 9.66 2.43 13.09 2.59 
32 11.97 2.68 14.67 2.88 9.41 2.33 12.79 2.49 
33 11.71 2.59 14.41 2.80 9.16 2.23 12.51 2.39 
34 11.45 2.51 14.16 2.73 8.93 2.13 12.25 2.30 
35 11.20 2.42 13.92 2.65 8.72 2.05 12.00 2.22 
36 10.96 2.34 13.68 2.57 8.50 1.96 11.76 2.14 
37 10.72 2.26 13.45 2.49 8.30 1.88 11.52 2.05 
38 10.49 2.17 13.22 2.41 8.10 1.80 11.29 1.97 
39 10.27 2.09 13.00 2.33 7.90 1.71 11.07 1.89 























Appendix 2.D Break-even weight gain calculated via alternative lifetime weight trajectories 
(Model II and Model III).  
 
Table 2.D.1 Break-even weight gain in BMI units for males with high SES under permanent 
weight gain (Model II).  
  
White Male Black Male 
Initial BMI/ Quit-Age 50 60 70 80 50 60 70 80 
25 9.73 6.45 4.12 2.38 9.88 6.47 4.36 2.53 
26 9.71 6.37 3.81 1.83 9.84 6.34 3.96 1.94 
27 9.69 6.3 3.65 1.58 9.81 6.25 3.74 1.64 
28 9.67 6.25 3.53 1.47 9.78 6.18 3.59 1.5 
29 9.66 6.21 3.46 1.42 9.76 6.13 3.49 1.42 
30 9.65 6.19 3.42 1.38 9.74 6.08 3.41 1.37 
31 9.64 6.17 3.38 1.36 9.73 6.05 3.36 1.34 
32 9.64 6.15 3.36 1.34 9.71 6.02 3.32 1.32 
33 9.63 6.14 3.34 1.33 9.7 5.99 3.29 1.3 
34 9.62 6.13 3.33 1.33 9.69 5.97 3.27 1.29 
35 9.62 6.12 3.32 1.32 9.68 5.96 3.25 1.28 
36 9.62 6.11 3.31 1.32 9.67 5.94 3.24 1.28 
37 9.61 6.1 3.3 1.31 9.66 5.93 3.23 1.27 
38 9.61 6.1 3.3 1.31 9.66 5.92 3.21 1.27 
39 9.61 6.09 3.29 1.31 9.65 5.91 3.21 1.26 



























Table 2.D.2 Break-even weight gain in BMI units for females with high SES under permanent 
weight gain (Model II).  
 
 White Female Black Female 
Initial BMI/Quit-Age 50 60 70 80 50 60 70 80 
25 11.36 7.59 4.64 2.51 11.41 7.69 4.97 2.77 
26 11.34 7.51 4.36 1.96 11.37 7.56 4.59 2.19 
27 11.33 7.45 4.2 1.74 11.34 7.47 4.37 1.88 
28 11.31 7.41 4.1 1.65 11.31 7.4 4.22 1.72 
29 11.3 7.38 4.04 1.6 11.29 7.34 4.11 1.64 
30 11.3 7.36 4.01 1.57 11.27 7.3 4.04 1.59 
31 11.29 7.34 3.98 1.56 11.25 7.26 3.99 1.56 
32 11.29 7.33 3.97 1.55 11.24 7.23 3.96 1.54 
33 11.28 7.32 3.95 1.54 11.23 7.21 3.93 1.53 
34 11.28 7.31 3.94 1.53 11.22 7.19 3.91 1.52 
35 11.27 7.3 3.94 1.53 11.21 7.17 3.89 1.51 
36 11.27 7.3 3.93 1.53 11.2 7.16 3.88 1.51 
37 11.27 7.29 3.93 1.53 11.19 7.15 3.87 1.51 
38 11.27 7.29 3.92 1.52 11.18 7.14 3.86 1.5 
39 11.26 7.29 3.92 1.52 11.18 7.13 3.85 1.5 


























Table 2.D.3 Break-even weight gain in BMI units for males with low SES under permanent 
weight gain (Model II).  
  
White Male Black Male 
Initial BMI/ Quit-Age 50 60 70 80 50 60 70 80 
25 9.77 6.53 4.23 2.44 9.93 6.56 4.46 2.59 
26 9.75 6.43 3.89 1.88 9.89 6.41 4.04 1.99 
27 9.72 6.35 3.71 1.62 9.85 6.31 3.8 1.68 
28 9.7 6.3 3.58 1.49 9.82 6.23 3.65 1.52 
29 9.69 6.25 3.5 1.43 9.8 6.17 3.53 1.43 
30 9.67 6.22 3.44 1.39 9.78 6.12 3.45 1.38 
31 9.66 6.19 3.4 1.37 9.76 6.08 3.39 1.35 
32 9.65 6.17 3.38 1.35 9.74 6.05 3.35 1.33 
33 9.65 6.16 3.36 1.34 9.73 6.02 3.31 1.31 
34 9.64 6.14 3.34 1.33 9.72 6 3.29 1.3 
35 9.63 6.13 3.33 1.32 9.7 5.98 3.27 1.29 
36 9.63 6.12 3.32 1.32 9.69 5.96 3.25 1.28 
37 9.62 6.11 3.31 1.32 9.68 5.95 3.24 1.27 
38 9.62 6.11 3.3 1.31 9.68 5.93 3.22 1.27 
39 9.62 6.1 3.29 1.31 9.67 5.92 3.21 1.26 






























Table 2.D.4 Break-even weight gain in BMI units for females with low SES under permanent 
weight gain (Model II).  
 
 White Female Black Female 
Initial BMI/Quit-Age 50 60 70 80 50 60 70 80 
25 11.41 7.67 4.75 2.57 11.47 7.79 5.08 2.84 
26 11.38 7.57 4.44 2.02 11.42 7.64 4.67 2.25 
27 11.36 7.5 4.26 1.77 11.39 7.53 4.43 1.91 
28 11.34 7.45 4.14 1.66 11.36 7.45 4.28 1.75 
29 11.33 7.41 4.07 1.61 11.33 7.39 4.16 1.66 
30 11.32 7.38 4.03 1.58 11.31 7.34 4.08 1.61 
31 11.31 7.36 4 1.56 11.29 7.3 4.02 1.57 
32 11.3 7.34 3.98 1.55 11.27 7.27 3.98 1.55 
33 11.29 7.33 3.96 1.54 11.26 7.24 3.95 1.54 
34 11.29 7.32 3.95 1.54 11.24 7.22 3.93 1.53 
35 11.28 7.31 3.94 1.53 11.23 7.2 3.91 1.52 
36 11.28 7.31 3.94 1.53 11.22 7.18 3.89 1.51 
37 11.28 7.3 3.93 1.53 11.21 7.17 3.88 1.51 
38 11.27 7.3 3.93 1.52 11.2 7.16 3.87 1.5 
39 11.27 7.29 3.92 1.52 11.2 7.15 3.86 1.5 


























Table 2.D.5 Break-even weight gain in BMI units for males with high SES under permanent 
weight gain (Model III).  
  
White Male Black Male 
Initial BMI/ Quit-Age 50 60 70 80 50 60 70 80 
25 10.16 7.07 4.89 2.98 10.37 7.19 5.18 3.17 
26 10.13 6.96 4.54 2.42 10.33 7.01 4.78 2.56 
27 10.11 6.87 4.33 2.05 10.29 6.89 4.52 2.17 
28 10.09 6.81 4.17 1.83 10.26 6.8 4.32 1.91 
29 10.07 6.75 4.05 1.7 10.23 6.73 4.17 1.74 
30 10.05 6.7 3.95 1.61 10.21 6.67 4.05 1.64 
31 10.04 6.66 3.87 1.55 10.19 6.62 3.95 1.56 
32 10.02 6.63 3.8 1.5 10.17 6.58 3.87 1.51 
33 10.01 6.6 3.74 1.47 10.15 6.53 3.8 1.47 
34 10 6.57 3.69 1.44 10.13 6.5 3.74 1.44 
35 9.99 6.54 3.65 1.42 10.12 6.47 3.69 1.41 
36 9.98 6.52 3.61 1.41 10.11 6.44 3.65 1.39 
37 9.97 6.5 3.58 1.39 10.1 6.42 3.6 1.37 
38 9.96 6.48 3.56 1.38 10.09 6.39 3.57 1.36 
39 9.95 6.47 3.54 1.37 10.07 6.37 3.54 1.35 































Table 2.D.6 Break-even weight gain in BMI units for females with high SES under permanent 






















 White Female Black Female 
Initial BMI/Quit-Age 50 60 70 80 50 60 70 80 
25 11.64 7.96 5.14 2.94 11.78 8.18 5.56 3.29 
26 11.62 7.88 4.84 2.42 11.74 8.05 5.19 2.72 
27 11.6 7.82 4.66 2.08 11.71 7.95 4.96 2.34 
28 11.59 7.77 4.53 1.89 11.69 7.88 4.79 2.08 
29 11.58 7.73 4.43 1.79 11.67 7.82 4.65 1.93 
30 11.56 7.7 4.35 1.72 11.65 7.77 4.55 1.83 
31 11.55 7.66 4.28 1.68 11.63 7.72 4.47 1.76 
32 11.54 7.64 4.23 1.64 11.62 7.68 4.4 1.71 
33 11.53 7.61 4.19 1.62 11.6 7.65 4.33 1.68 
34 11.53 7.59 4.16 1.6 11.59 7.62 4.28 1.64 
35 11.52 7.58 4.13 1.59 11.58 7.59 4.23 1.62 
36 11.51 7.56 4.11 1.58 11.57 7.57 4.2 1.6 
37 11.5 7.54 4.09 1.57 11.56 7.55 4.16 1.59 
38 11.5 7.53 4.07 1.56 11.55 7.53 4.14 1.58 
39 11.49 7.51 4.06 1.56 11.54 7.51 4.11 1.57 





Table 2.D.7 Break-even weight gain in BMI units for males with low SES under permanent 
weight gain (Model III).  
  
White Male Black Male 
Initial BMI/ Quit-Age 50 60 70 80 50 60 70 80 
25 9.97 6.78 4.57 2.78 10.16 6.87 4.87 2.97 
26 9.95 6.71 4.26 2.25 10.13 6.74 4.49 2.39 
27 9.94 6.64 4.08 1.91 10.1 6.65 4.26 2.03 
28 9.92 6.59 3.95 1.72 10.08 6.58 4.09 1.79 
29 9.91 6.55 3.85 1.61 10.06 6.52 3.96 1.66 
30 9.89 6.51 3.77 1.54 10.04 6.48 3.86 1.57 
31 9.88 6.48 3.7 1.49 10.02 6.44 3.78 1.51 
32 9.87 6.46 3.65 1.46 10.01 6.4 3.71 1.46 
33 9.87 6.44 3.6 1.43 10 6.37 3.66 1.43 
34 9.86 6.41 3.57 1.41 9.99 6.34 3.61 1.4 
35 9.85 6.39 3.54 1.39 9.98 6.31 3.56 1.38 
36 9.84 6.38 3.51 1.38 9.97 6.29 3.53 1.36 
37 9.84 6.36 3.49 1.37 9.96 6.27 3.5 1.35 
38 9.83 6.35 3.47 1.36 9.95 6.25 3.47 1.34 
39 9.83 6.33 3.46 1.35 9.94 6.24 3.45 1.33 































Table 2.D.8 Break-even weight gain in BMI units for females with low SES under permanent 























 White Female Black Female 
Initial BMI/Quit-Age 50 60 70 80 50 60 70 80 
25 11.49 7.72 4.81 2.73 11.57 7.88 5.23 3.07 
26 11.47 7.67 4.58 2.22 11.55 7.78 4.9 2.53 
27 11.46 7.63 4.44 1.94 11.53 7.71 4.7 2.17 
28 11.45 7.59 4.34 1.8 11.51 7.66 4.56 1.97 
29 11.44 7.56 4.26 1.72 11.5 7.61 4.45 1.84 
30 11.43 7.54 4.2 1.67 11.48 7.57 4.37 1.76 
31 11.43 7.51 4.15 1.63 11.47 7.54 4.3 1.7 
32 11.42 7.49 4.11 1.61 11.46 7.51 4.24 1.66 
33 11.41 7.48 4.09 1.59 11.45 7.49 4.19 1.63 
34 11.41 7.46 4.07 1.58 11.44 7.46 4.15 1.61 
35 11.4 7.45 4.05 1.57 11.43 7.44 4.12 1.59 
36 11.4 7.44 4.03 1.56 11.42 7.43 4.09 1.58 
37 11.39 7.43 4.02 1.55 11.42 7.41 4.06 1.56 
38 11.39 7.42 4.01 1.55 11.41 7.39 4.04 1.56 
39 11.38 7.41 4 1.54 11.4 7.38 4.03 1.55 





Table 2.D.9 Break-even weight gain in BMI units for smokers with high SES under diminishing 
weight gain (Model II).  
 
 White Male White Female Black Male Black Female 
Initial BMI/Quit-Age 70 80 70 80 70 80 70 80 
25 14.98 4.48 17.77 4.75 12.78 4.25 16.25 4.87 
26 14.19 3.48 16.72 3.71 11.89 3.26 15.07 3.79 
27 13.6 3.1 15.93 3.31 11.26 2.76 14.25 3.22 
28 13.04 2.9 15.32 3.09 10.73 2.51 13.59 2.9 
29 12.6 2.75 14.85 2.93 10.25 2.32 13.01 2.68 
30 12.23 2.62 14.47 2.81 9.84 2.18 12.55 2.5 
31 11.89 2.51 14.14 2.7 9.51 2.06 12.17 2.36 
32 11.59 2.41 13.83 2.6 9.2 1.96 11.84 2.24 
33 11.3 2.31 13.55 2.51 8.92 1.86 11.54 2.13 
34 11.02 2.22 13.28 2.42 8.67 1.77 11.26 2.03 
35 10.76 2.13 13.02 2.33 8.43 1.69 11 1.93 
36 10.51 2.04 12.77 2.24 8.2 1.61 10.76 1.84 
37 10.27 1.95 12.52 2.15 7.99 1.53 10.52 1.75 
38 10.03 1.87 12.29 2.06 7.78 1.46 10.3 1.66 
39 9.8 1.78 12.05 1.97 7.58 1.38 10.08 1.57 



























Table 2.D.10 Break-even weight gain in BMI units for smokers with low SES under diminishing 
weight gain (Model II).  
 
 White Male White Female Black Male Black Female 
Initial BMI/Quit-Age 70 80 70 80 70 80 70 80 
25 15.18 4.62 18.12 4.92 74.28 28.98 12.96 4.37 
26 14.48 3.63 17.2 3.87 73.29 28.2 12.12 3.39 
27 14 3.21 16.47 3.44 72.35 27.57 11.58 2.87 
28 13.49 3.02 15.84 3.22 71.48 26.98 11.09 2.62 
29 13.06 2.88 15.37 3.07 70.66 26.44 10.64 2.44 
30 12.68 2.75 14.98 2.94 69.87 25.94 10.23 2.3 
31 12.35 2.64 14.63 2.83 69.13 25.47 9.89 2.18 
32 12.04 2.54 14.32 2.73 68.43 25.03 9.58 2.08 
33 11.75 2.44 14.03 2.64 67.75 24.6 9.3 1.98 
34 11.47 2.35 13.75 2.55 67.09 24.2 9.04 1.89 
35 11.21 2.26 13.49 2.46 66.47 23.83 8.8 1.81 
36 10.95 2.17 13.23 2.37 65.87 23.47 8.57 1.72 
37 10.71 2.08 12.99 2.28 65.28 23.12 8.34 1.64 
38 10.47 1.99 12.75 2.19 64.72 22.79 8.13 1.56 
39 10.23 1.9 12.51 2.09 64.18 22.47 7.92 1.49 


























Table 2.D.11 Break-even weight gain in BMI units for smokers with high SES under diminishing 
weight gain (Model III).  
 
 White Male White Female Black Male Black Female 
Initial BMI/Quit-Age 70 80 70 80 70 80 70 80 
25 14.74 4.47 16.5 4.49 12.75 4.3 15.47 4.69 
26 13.25 3.33 14.89 3.33 11.36 3.16 13.76 3.48 
27 12.17 2.52 13.77 2.49 10.31 2.37 12.56 2.6 
28 11.25 1.93 12.89 1.93 9.41 1.76 11.61 1.9 
29 10.47 1.48 12.13 1.53 8.64 1.28 10.79 1.4 
30 9.78 1.13 11.46 1.22 7.97 0.9 10.11 1 
31 9.16 0.82 10.84 0.96 7.38 0.6 9.49 0.67 
32 8.58 0.56 10.31 0.73 6.85 0.32 8.93 0.39 
33 8.05 0.33 9.82 0.53 6.37 0.09 8.4 0.14 
34 7.56 0.12 9.38 0.33 5.91 0 7.92 0 
35 7.11 0 8.97 0.15 5.49 0 7.46 0 
36 6.68 0 8.58 0 5.1 0 7.05 0 
37 6.3 0 8.21 0 4.72 0 6.66 0 
38 5.92 0 7.86 0 4.36 0 6.29 0 
39 5.56 0 7.52 0 4.03 0 5.94 0 


























Table 2.D.12 Break-even weight gain in BMI units for smokers with low SES under diminishing 
weight gain (Model III).  
 
 White Male White Female Black Male Black Female 
Initial BMI/Quit-Age 70 80 70 80 70 80 70 80 
25 14.06 4.21 15.44 4.21 12.24 4.06 14.57 4.4 
26 12.58 3.1 14.08 3.05 10.77 2.95 12.95 3.22 
27 11.54 2.33 13.12 2.28 9.74 2.18 11.86 2.34 
28 10.71 1.78 12.35 1.8 8.89 1.6 10.99 1.73 
29 9.99 1.39 11.67 1.47 8.17 1.16 10.27 1.27 
30 9.36 1.07 11.09 1.21 7.57 0.82 9.65 0.92 
31 8.78 0.8 10.57 0.98 7.02 0.98 9.09 0.63 
32 8.26 0.57 10.12 0.78 6.54 0.54 8.57 0.38 
33 7.79 0.36 9.71 0.59 6.09 0.3 8.1 0.14 
34 7.36 0.16 9.31 0.42 5.67 0.09 7.67 0 
35 6.96 0 8.95 0.25 5.28 0 7.27 0 
36 6.58 0 8.6 0.08 4.92 0 6.91 0 
37 6.23 0 8.26 0 4.58 0 6.54 0 
38 5.88 0 7.93 0 4.26 0 6.21 0 
39 5.55 0 7.61 0 3.95 0 5.89 0 


























Appendix 2.E Sensitivity analysis with varying discounting rates. 
 
Figure 2.E.1 Sensitivity analysis of average break-even weight gain (BMI) for white males under 
permanent weight gain. 
  
 
Note. Orange bar = average break-even weight gain in units of BMI for white males with 1% discounting rate; blue 


























Figure 2.E.2 Sensitivity analysis of average break-even weight gain (BMI) for white females 
under permanent weight gain.  
 
 
Note. Orange bar = average break-even weight gain in units of BMI for white females with 1% discounting rate; 





























Figure 2.E.3 Sensitivity analysis of average break-even weight gain (BMI) for black males under 
permanent weight gain.  
 
 
Note. Orange bar = average break-even weight gain in units of BMI for black males with 1% discounting rate; blue 





























Figure 2.E.4 Sensitivity analysis of average break-even weight gain (BMI) for black females 
under permanent weight gain.  
 
 
Note. Orange bar = average break-even weight gain in units of BMI for black females with 1% discounting rate; 





























Figure 2.E.5 Sensitivity analysis of break-even weight gain (BMI) for white males under 
diminishing weight gain.  
 
 
Note. Blue dashed curve = break-even weight gain in units of BMI for white males with 1% discounting rate; grey 




























Figure 2.E.6 Sensitivity analysis of break-even weight gain (BMI) for white females under 
diminishing weight gain.  
 
 
Note. Blue dashed curve = break-even weight gain in units of BMI for white females with 1% discounting rate; grey 




























Figure 2.E.7 Sensitivity analysis of break-even weight gain (BMI) for black males under 
diminishing weight gain.  
 
 
Note. Blue dashed curve = break-even weight gain in units of BMI for black males with 1% discounting rate; grey 




























Figure 2.E.8 Sensitivity analysis of break-even weight gain (BMI) for black females under 
diminishing weight gain.  
 
 
Note. Blue dashed curve = break-even weight gain in units of BMI for black females with 1% discounting rate; grey 



















Estimating Health Benefits Gained from Reduction in Post-Cessation Weight 
Gain: An Agent-Based Modelling Approach 
 
3.1 Background 
While smoking cessation leads to gains in health benefits, it is often accompanied by a significant 
increase in body weight as well, referred to as post-cessation weight gain. Concern about post-
cessation weight gain has served as a barrier against quitting, especially among women [1-3]. At 
the same time, post-cessation weight gain attenuates the benefit of smoking cessation. It 
contributes to an increased risk of type 2 diabetes in the short run, hypertension, and a reduced 
improvement of lung function [4,5].  
 
Despite the wide variability in post-cessation weight gain, little is known about key predictors of 
weight gain. There is some evidence that on average women gain more weight than men after 
quitting [6,7]. Using the Lung Health Study, Ohara et al. found that for quitters with sustained 
abstinence for 5 years, women gained a mean of 5.2 kg in year 1 and a mean of 3.4 kg in years 1-
5 while men gained an average of 4.9 kg in year 1 and a mean of 2.6 kg in years 1-5 [7]. In addition, 
heavy smokers tend to experience more weight gain [8,9]. Heavy smokers, who smoke more than 
25 cigarettes a day, are almost six times more likely to gain more than 13 kg after cessation 





A few studies also examined the impact of baseline Body Mass Index (BMI) on the amount of 
post-cessation weight gain, but their findings are inconsistent [7,10,11]. Some found that higher 
baseline BMI is associated with a higher initial post-cessation weight gain [7,11,12], while others 
discovered a negative or zero association between the two [12-14]. O’Hara reported a higher 
amount of weight gain after quitting among smokers with higher baseline BMI [7]. Lycett 
examined POST-CESSATION WEIGHT GAIN in a clinical trial and discovered that obese 
smokers gained the most weight in 8 years [11]. However, Krukowski and colleagues reported that 
normal and overweight recent quitters gaining the most significant amounts of weight [10]. 
Similarly, Veldheer et al. found that normal and overweight smokers gained the most weight after 
quitting in 10 years [14]. 
 
Other factors contributing to higher post-cessation weight gain include lower socio-economic 
status (SES) and younger quit-age [9,15].  Swan and Carmelli reported that among male former 
smokers, super-gainers, those who gained more than 13 kg (28.6 lbs) after quitting, were younger 
and with lower SES [15]. Klesges and colleagues concluded that lower educational attainment is 
associated with greater initial weight gain [12]. For both genders, people under the age of 55 and 
who were heavy smokers were associated with higher risk of major weight gain [9]. 
 
A literature review conducted by Farley et al. examined various interventions to deal with post-
cessation weight gain [16]. These interventions can be divided into three broad categories: 1. 
Pharmacological treatment; 2. Weight-related behavioral intervention; and 3. Electronic cigarette 
(EC). Pharmacological treatment can be further categorized into first-line and second-line 




replacement therapies (NRTs), bupropion, and varenicline. Some second-line treatments are 
clonidine and nortriptyline. These treatments block the positive reinforcing effect of nicotine and 
prevent or reduce nicotine withdrawal symptoms [17]. However, these medications appear to delay, 
rather than prevent post-cessation weight gain. A significant reduction in weight gain is discovered 
at the end of the treatment but there is no evidence that these treatments reduced weight in the long 
run at 6 or 12 months [18]. NRT, bupropion, and varenicline were reported to reduce weight gain 
by 0.5 kg, 1.1 kg and 0.4 kg, respectively, at the end of the treatment [16].  
 
Weight-related behavioral interventions include personalized weight management support, 
exercise interventions and energy restriction or healthy eating advice [16,18,19]. Most behavioral 
interventions aim to minimize post-cessation weight gain by limiting calorie intake [20,21], 
enhancing energy expenditure [22,23] or a combination of both [24-26].  A systematic review done 
on behavior interventions by Spring et al. found significant effect in the short run [27]. Farley et 
al. reported that both personalized weight management support and exercise interventions reduced 
weight gain significantly at 12 months, but the short run reduction was not significant [16].  
 
Another innovative approach to deal with post-cessation weight gain is to use alternative tobacco 
product such as EC. EC is a battery-operated device designed to vaporize an e-liquid by heating 
an element that generates an inhalable aerosol. This process is referred to as vaping. EC does not 
contain tobacco, do not create smoke and do not rely on combustion to operate [28]. Many smokers 
use EC to help quit or reduce smoking [29,30]. Recent studies show that EC attenuates tobacco 
withdrawal symptoms as effectively as NRT [31,32l]. Russo et al. investigated changes in body 




use [28,33]. They found that quitters gained a significant 4.8% weight from baseline at 12 months 
after cessation while weight gain for EC users was only 1.5% of baseline [33]. ECs is considered 
as a tobacco harm reduction mechanism. Smokers who switch to EC achieve large but not full 
health gains of cessation [34]. In addition, they are more likely to quit [35]. Among dual users, 46% 
quit smoking altogether after 1 year [29,31].  
 
In this study, I estimate health benefits gained from reduction in post-cessation weight gain where 
three different interventions are implemented. My main outcome measures are life-years saved, 
cumulative survival probability and obesity prevalence at the population level. These interventions 
are pharmacological treatment, EC and behavioral intervention. I first simulate a nationally 
representative sample of adult smokers in the US via the National Health Interview Survey (NHIS) 
in 2017. Then I apply interventions dealing with both smoking cessation rates and post-cessation 
weight gain, assuming a 100% participation rate. The model mentioned above is implemented via 
an agent-based model to account for population heterogeneity, where differential mortality is 
applied based on demographic characteristics and weight trajectories. The model tracks BMI and 
survival information for each simulated smoker over 20 years as outcome measures. The agent-
based model is implemented via Python programming.  
 
3.2 Methods 
Study Population  
I obtained demographic information of adult smokers in the US from the NHIS 2017 dataset. The 
NHIS has monitored the health of the US population since 1957. NHIS data are collected on a 




households are surveyed each year.  This dataset is open to public and I mapped the 2017 
population onto the agent-based model at baseline.  
 
I started with 4,015 smokers, excluded individuals who have missing BMI values (121); missing 
smoking intensity (81); under 18 years-old (15); missing race information (203); missing height 
values (238); and missing data on educational achievement (16). My final sample includes 3341 
adult smokers. In addition to adopting the NHIS sample as the initial population, I also used 
bootstrap method to generate random samples with 10,000 smokers where survey weights from 
the NHIS were incorporated. I refer to these two samples as the NHIS sample and the random 
sample. Table 3.1 provides a summary of baseline characteristics from both the NHIS sample and 
the random sample. In both samples, average age initially is in the mid to late 40s. There are 
slightly more males among smokers, 55.15% (random sample) and 51.63% (NHIS sample). The 
majority of the smokers are white, 85.5% vs 86.95%. Both samples have around 30% of the 
population that are obese. And majority of the smokers have finished high school (84.27% vs 
83.12%). One parameter I added in the sample is POST-CESSATION WEIGHT GAIN. I assume 
it has a normal distribution with a mean of 10.3 lbs per the results from Aubin et al. [36].   
 
Table 3.1 Baseline characteristics of adult smokers in the simulated cohort vs the National 
Health Interview Survey, 2017. 
 
Lifetime weight trajectory  
The lifetime weight trajectories for current smokers are calculated, adjusting for age, gender, race, 
BMI from previous survey, and SES (high school graduate or not). I used 12 waves of the Health 




representative sample of the US population every two years. It is conducted by the Survey 
Research Center at the University of Michigan and sponsored by the National Institute on Aging. 
At the baseline in 1992, a total of 12,652 individuals from 7,702 households participated. My 
sample includes only this initial HRS cohort who joined the study in 1992. A few exclusion criteria 
are applied to obtain my final sample. The flowchart below in Figure 3.1 illustrates the process. I 
tracked all twelve waves of data (1992 till 2014) to investigate how BMI changes with respect to 
smoking behavior and demographic variables over time.  
 
Figure 3.1 Flowchart for selecting eligible participants in the final sample from the Health and 
Retirement Study. 
 
My final sample includes 9,606 unique individuals and 69,745 person-year observations. At 
baseline, the average age is 55.22 years, 43.04% of participants are male, 80.23% of them are 
white and the average BMI is 26.99. The obesity rate is 22.93%, 81% are married and around 70% 
have degrees of high school or above. See Appendix 3.A for more details. 
 
To estimate the lifetime weight trajectory of individuals adjusting for smoking behaviors and 
demographic information, I ran linear regressions to predict the percentage change of BMI 
between any two consecutive surveys adjusting for individual level clustering. I used Stata version 
14.0 (StataCorp LP, College Station, TX) to conduct this analysis. My dependent variable is the 
percentage change of BMI between any two consecutive surveys and my independent variables 
include age, gender, race, SES, and BMI from previous survey. Regression results can be found in 






An article published by the Global BMI Mortality Collaboration assessed the impact of BMI on 
all-cause mortality [21]. Using their hazard ratio estimates for various BMI levels controlling for 
gender, I calculated the RR for obesity as a function of BMI for both genders. For BMI over 25, 
mortality rate increases log-linearly, adjusting for gender [21]. To calculate the RR of mortality 
adjusting for smoking behaviors, I employed the all-cause mortality RR calculated in Mendez and 
Warner’s work [22]. They derived the RR for current and former smokers as a function of age, 
gender, and years quit via logistic regressions.  
 
Another important piece is the all-cause mortality rate for the control group. In Mendez and 
Warner’s work, the baseline risk used is the mortality rate for never-smokers [22]. For obesity-
related RR, the hazard ratio is 1 for normal-weight individuals with a BMI between 18.5 and 25. 
The baseline mortality rate in this study is the one for normal-weight never-smokers. From a recent 
publication of the National Vital Statistics Reports, I obtained annual mortality rates in the US by 
race and gender in 2016 [23]. I then combined the mortality rates with a group prevalence weight 
calculated from the National Health Interview Survey (NHIS) to derive estimates for normal-
weight never-smokers. I counted the impact of smoking and obesity on all-cause mortality as 
additive per the results from Mehta and Preston’s work [24]. The age-specific annual mortality 
rates by gender and race from age 40 to 100 for normal-weight never-smokers can be found in 
Table 3.2.  
 








The tool I employed to investigate the effectiveness of these interventions is agent-based modeling 
(ABM). ABM, a relatively new method in the social science arsenal, has enabled scholars to 
investigate behaviors and social interactions at individual or organizational levels. ABM can 
incorporate various individual and environmental characteristics into the model to account for 
population heterogeneity. In this study, ABM accounts for population heterogeneity by 
incorporating demographic information for each simulated agent. Through ABM, I first simulated 
a nationally representative sample of the US adult smokers using NHIS data in 2017. Then I 
evaluated the impact of three interventions on this simulated population. My outcome measures 
are life-years saved and obesity prevalence over 20 years at the population level.  
 
Initially in my model at Year 1, all individuals are smokers. Here one time-step in the model is 
one year. Year 1 (baseline) is 2017 and Year 2 is 2018. At each time-step in the model, I simulated 
potential smoking behavioral changes. If smokers continue smoking, their weight trajectories 
follow the ones I predict via regression models. If smokers quit, they experience a post-cessation 
weight increase. This weight increase remains permanent on top of their weight trajectories 
assuming if they were continuing smokers. Based on the literature review conducted by Aubin et 
al., the average post-cessation weight gain in the population is around 10.3 lbs with a variance of 
0.79 lbs.  
 
I tracked all simulated individuals over a 20-year horizon, aka 20 time-steps. I examined the 
survival rate by counting the number of individuals who survive after each time step. Age, sex and 
race adjusted all-cause mortality rate, together with relative risk of BMI and smoking status, are 




rounds of simulation for each data point to account for randomness in the model.  The results 
presented are averages across all 200 rounds of simulation. A step-by-step description of the model 
can be found in the Appendix 3.C.  
 
Interventions 
In order to investigate the effectiveness of interventions, I created a control group with no 
interventions and implement a total of three interventions on the same initial population. These 
interventions adopted are pharmacotherapy (bupropion treatment), behavioral intervention 
(physical activity program) and EC.  
 
Control Group: smoking cessation only  
Intervention I: smoking cessation + pharmacotherapy (bupropion)  
Intervention II: smoking cessation + behavioral intervention (physical activity program)  
Intervention III: smoking cessation + electronic cigarette 
 
A brief summary of these interventions can be found in Table 3.3 below. I selected these 
interventions because they are randomized control trials (RCTs) that provide more accurate 
estimates of intervention effectiveness. A more detailed description of these RCTs can be found 
in Appendix 3.D.  The pharmacotherapy program implements bupropion as a pharmacotherapy to 
reduce post-cessation weight gain. The effectiveness estimation is from a 7-week RCT conducted 
by Nides et al. [37]. The behavioral intervention is a physical activity program where individuals 
enroll for 9 weeks with structured and lifestyle components [38]. Intervention EC helps smokers 
to switch to electronic cigarette. The treatment group includes both dual users (cigarettes + 
electronic cigarettes) and exclusive users (electronic cigarette only). There is no significant 




Table 3.3. Summary of interventions. 
 
I converted the post-cessation weight gain values in these interventions to relative weight gains in 
percentage points, using quitters in the control group as the reference group. Similarly, I derived 
the impact of interventions on smoking cessation rate to relative values in percentage points 
[33,37,38]. Table 3.4 below summarizes the parameter values for all three interventions. For 
example, 1.29 for pharmacotherapy under smoking cessation rate means pharmacotherapy 
intervention increases the smoking cessation rate by 29 percentage points, compared with the 
control group. 0.47 for electronic cigarette under post-cessation weight gain implies that smokers 
who switch to electronic cigarette experience 53 percentage points reduction in post-cessation 
weight gain at the end of one year. Since we know the population average smoking cessation rate 
is around 4.5% [39] and the weight gain has a normal distribution with mean of 10.3 lbs [36], I 
adjusted these rates according to the simulated interventions in the model. In Table 3, 
pharmacotherapy only increases smoking cessation rate but does not affect post-cessation weight 
gain in the long run. Physical activity, on the other hand, helps with post-cessation weight increase 
but does nothing to smoking cessation rate. Electronic cigarette seems to be the most desirable 
intervention since it raises smoking cessation rate and reduces weight gain post-cessation.  
 
Table 3.4 Value of parameters in the model estimating effectiveness of interventions. 
 
Scenarios  
I modeled two different scenarios: Scenario I vs Scenario II. In Scenario I, all smokers quit 
smoking in Year 1 and do not relapse. In this scenario, the model only assesses the impact of 
interventions via their reductions in post-cessation weight gain. Since the cessation rate is 100% 




cessation. In Scenario II, a population level quit rate of 4.5% is added to the model [39]. In Scenario 
II, interventions not only decrease weight increase but also increases smoking cessation rate, 
generating a more complex impact on the population. These interventions are implemented in Year 
1 only, where they affect both the smoking cessation rate and post-cessation weight increase. 
 
3.4 Results 
In Scenario I where I assumed the smoking cessation rate to be 100% in Year 1, since 
pharmacotherapy has no effect on post-cessation weight gain, status quo with no interventions 
generate the same results as pharmacotherapy. I thus omit the results from pharmacotherapy and 
only list status quo with two other interventions (physical activity and EC). Table 3.5 presents the 
cumulative survival probability over twenty years under the random sample and the NHIS sample. 
Under the random sample, both EC and physical activity interventions increased cumulative 
survival probability and the increases are statistically significant. In 5 years, if smokers switch to 
electronic cigarette, their survival rate will increase by around 0.23 percentage point. If they 
participate in physical activity interventions, their survival rate will increase by 0.04 percentage 
point. By the end of twenty years, differences grow to 1.19 percentage points for EC and 0.16 
percentage point for physical activity intervention.  Similar results can be found with the NHIS 
sample. EC intervention on average generates higher cumulative survival probability compared to 
physical activity or the status quo. One minor difference is that in the NHIS sample, the survival 
probability under physical activity is not statistically different from the status quo at Year 5, but it 
is post Year 10. Although these significant changes are not large, considering we have around 34 
million adult smokers in the US currently, the potential life-years saved is huge. 
 




Table 3.6 shows the variation of average obesity prevalence over 20 years. In Table 6 with the 
random sample, EC and physical activity both reduce obesity prevalence in the population 
significantly since Year 5. At Year 5, obesity prevalence is reduced by 6.68 percentage points via 
electronic cigarette intervention and by 4.22 percentage points via physical activity. At the end of 
twenty years, these reductions are further increased to 9.68 and 5.26 percentage points respectively.  
 
Table 3.6. Average obesity prevalence in Scenario I, where all smokers quit. 
 
 
Figure 3.2 illustrates the cumulative survival probability by year comparing status quo with two 
interventions with the random sample. EC intervention generates a bigger impact than physical 
activity. The impact of these interventions on average obesity prevalence with 100% cessation rate 
is shown in Figure 3.3. The initial jump from Year 1 to Year 2 is the result of cessation. It is 
obvious that both interventions decrease obesity prevalence significantly. Results regarding the 
NHIS sample can be found in Appendix 3.E.  
 
Figure 3.2. Average cumulative survival probability in one-year increments under the random 
sample in Scenario I, where all smokers quit. 
Figure 3.3 Average obesity prevalence in one-year increments under the random sample in 
Scenario I, where all smokers quit. 
 
Then I examined the outcomes from Scenario II in Table 3.7, where the cessation rate is 4.5% and 
the impact of interventions on smoking cessation are added. In both random sample and the NHIS 
sample, pharmacotherapy generates minor improvement to the cumulative survival probability. 
This improvement is not statistically significant in the short run. Similarly, physical activity creates 




and 0.13 percentage point in the random and NHIS sample, respectively. EC seems to be the 
dominant intervention. It leads to higher cumulative survival probability and the improvement is 
significant post Year 10. By the end of twenty years, EC intervention increases the survival 
probability by approximately 1.2 percentage points. Translating these results into life-years saved 
in Table 3.8, we find that EC intervention could save 3,500 life-years in 5 years using the random 
sample. The estimated life-years saved increases to 238,000 in 20 years, which is a significant 
amount. 
 
Table 3.7. Cumulative survival probability in Scenario II, where status quo cessation rate is 
4.5%. 
Table 3.8. Life-Years Saved in Scenario II compared with status quo, where status quo cessation 
rate is 4.5%. 
 
Table 3.9 reveals the changes of average obesity prevalence over twenty years under different 
interventions. Both EC and physical activity are statistically significant at reducing obesity 
prevalence while pharmacotherapy actually increases the obesity prevalence. This is not 
unexpected. Pharmacotherapy is effective at increasing smoking cessation rate but does not help 
with post-cessation weight increases. With a growing number of quitters who might become obese 
via post-cessation weight gain, it is not surprising that pharmacotherapy intervention increases 
obesity prevalence and cumulative survival probability simultaneously. The differences in one-
year increments are illustrated via figures in Appendix 3.F.  
 










The health message given to smokers currently is that it is never too late to quit, without addressing 
the issue of post-cessation weight gain. The agent-based model established in this paper attempts 
to estimate the potential health benefits that could be gained if post-cessation weight gain is tackled 
via different interventions. In general, my results imply that all of these interventions improve 
cumulative survival probability significantly in the long run, with EC being the most effective.  
 
Another interesting finding is that smoking cessation can bring improvement to survival 
probability but can also increase the obesity prevalence. In Scenario II, when smokers participate 
in the pharmacotherapy intervention, they have a higher change to quit but no reduction in post-
cessation weight gain. The result shows a higher survival probability and a higher obesity 
prevalence. However, if smokers enroll in interventions that address post-cessation weight increase, 
they experience the better of both, higher survival probability and lower obesity prevalence. The 
findings show the perils of addressing these two major public health problems independently. The 
interaction between smoking behavior and body weight change makes it important for us to look 
at both obesity and smoking as one big problem.  
 
Findings from the model suggest that EC is very promising in increasing survival rate and reducing 
obesity prevalence. Quitting smoking and switching to electronic cigarette is considered as a harm 
reduction mechanism. Harm reduction in public health refers to the framework where health 
policies focus on decreasing the harmful consequences of drugs without fully eliminating the use 
[40]. ECs appear to be far less harmful than cigarettes, but the long-term effect remains unknown. 
For example, the 2018 National Academies of Sciences, Engineering, and Medicine Report found 




At the same time, the whole harm reduction strategy to tobacco control stays a controversial topic. 
While some are fond of the idea of harm reduction and view it as a promising progress towards 
elimination, others have concerns over lack of regulation, manipulation from tobacco companies 
and potential health disparities in the future. While this study recognizes electronic cigarette as a 
promising intervention to deal with POST-CESSATION WEIGHT GAIN for adult smokers, more 
research is needed to investigate long-term effects of electronic cigarette and update model results 
accordingly.   
 
Although physical activity intervention showed only marginal benefits in the model, it is 
potentially more beneficial due to its positive externalities. For example, physical activity helps to 
build muscle mass, promotes cardiometabolic wellness and improves cognitive performance 
[42,43]. In this model, I only captured impact of interventions via smoking cessation or post-
cessation weight change without including other potential mechanisms such as life style or diet 
change.   
 
This study also has some limitations. First, I assumed a normal distribution of weight increase and 
assigned it randomly to simulated individuals. Previous studies have shown that post-cessation 
weight increase is correlated with factors such as smoking intensity and gender. In the future, I 
plan to incorporate these correlations in my model to generate more accurate estimates of post-
cessation weight gain for individuals. Another limitation is the assumption of 100% participation 
rate in interventions. In the future, I plan to relax this assumption to allow more flexibility among 
the population. Better estimation of participation rates in the population can help us derive more 




of this study. Currently, the community has not yet reached an agreement on whether weight gain 
post-cessation diminishes or not [44,45]. In this model I assumed a permanent weight gain from 
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Tables and Figures 
 
Table 3.1 Baseline characteristics of adult smokers in the simulated cohort vs the National 
Health Interview Survey, 2017. 
 
Characteristics N = 10,000   
(Mean ± sd) 
N = 3,341  
(Mean ± sd) 
Age (years) 46.06 ± 15.38 48.4 ± 15.59 
Male (%)  55.13 51.63 
White Race (%) 85.5 86.95 
Body Mass Index (BMI)  27.81 ± 6.67 27.38 ± 5.5 
      Normal Weight (BMI < 25 𝑘𝑔/𝑚2) 36.7% 37.44% 
      Overweight (25 𝑘𝑔/𝑚2 ≤ BMI < 30 𝑘𝑔/𝑚2) 34.71% 34.51% 
      Obese (BMI  30 𝑘𝑔/𝑚2) 27.47% 28.05% 
Height (inch) 
Post-Cessation Weight Gain (lbs) 
67.32 ± 3.94 
10.3 ± 0.79 
67.26 ± 3.91 
10.3 ± 0.79 
Intensity of Smoking (%)   
      Light Smoker (1 – 10 cig/day)   61.01 58.72 
      Moderate Smoker (11 – 20 cig/day) 11.75 12.15 
      Heavy Smoker (20 cig/day)  27.24 29.12 
Education (%)    
      Less than High School 15.73 16.88 











Table 3.2 Age-specific annual mortality rates for normal-weight never-smokers by gender and  
race.  
 






































40-44 0.12 0.10 0.18 0.14 
45-49 0.16 0.14 0.22 0.19 
50-54 0.25 0.20 0.36 0.30 
55-59 0.36 0.30 0.53 0.43 
60-64 0.53 0.43 0.86 0.62 
65-69 0.73 0.63 1.12 0.86 
70-74 1.13 1.05 1.57 1.28 
75-79 1.86 1.79 2.20 1.99 
80-84 3.22 3.19 4.08 3.29 




Table 3.3 Summary of interventions.  

















Placebo for 7 
weeks.  
Bupropion hydrochloride 
was dosed for 7 weeks, 
with titration from 150 
mg once daily (days 1-3) 
to 150 mg twice daily 
through week 7. 
No difference 







481 9 weeks of 
smoking cessation 
9 weeks of smoking 
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Table 3.4 Value of parameters in the model estimating effectiveness of interventions. 
 Smoking Cessation Rate Post-Cessation Weight Gain 
Pharmacotherapy 1.29 1 
Electronic Cigarette 2.38 0.47 
Physical Activity 1 0.71 
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Status Quo E-cig Physical 
Activity 
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Standard errors are in parentheses 
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Table 3.8. Life-Years Saved in Scenario II compared with status quo, where status quo cessation 



































Standard errors are in parentheses 




























































































































Standard errors are in parentheses 














































13,593 individuals enrolled in 1992 
1 did not have birth information 
1,266 had inconsistent information 
on quit year. See Appendix X for 
more information 
298 former smokers did not report 
quit year 
1,050 did not report BMI in Wave 1 
10,978 individuals,                         
expand to 131,736 person-year 
observations 
 
55,557 experienced more than 30% 
of weight change between any two 
consecutive waves of interview 
76,179 person-year observations 
 
6,252 passed away within 5 years of 
the last survey 
69,927 person-year observations 
182 did not report accurate smoking 
cessation year 
9,606 eligible individuals with 




Figure 3.2. Average cumulative survival probability in one-year increments under the random 
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Figure 3.3 Average obesity prevalence in one-year increments under the random sample in 
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Appendix 3.A Baseline characteristics. 
 
Table 3.A.1 Baseline characteristics of the sample population, Health and Retirement Study 
1992.  
 
Characteristics N = 8,958 
Age (years) 55.22 ± 5.55 
Male (%)  43.03 
White Race (%) 80.23 
Weight (kg) 77.62 ± 16.62 
Body Mass Index (BMI)  26.99 ± 5.03 
      Normal Weight (BMI < 25 𝑘𝑔/𝑚2) 36.68 
      Overweight (25 𝑘𝑔/𝑚2 ≤ BMI < 30 𝑘𝑔/𝑚2) 40.39 
      Obese (BMI  30 𝑘𝑔/𝑚2) 22.93 
Height (m) 1.69 ± 0.099 
Smoking status (%)  
      Current Smoker  30.53 
      Former Smoker  25.11 
      Never Smoker  44.36 
Marital Status (%)  
      Married/Partnered 81.16 
      Single  2.88 
      Divorced/Widowed  15.95 
Education (%)   
      Less than High School 30.22 
      High School Graduate 33.05 
      Some College 19.41 
















Appendix 3.B Regression.  
 
Table 3.B.1 Regression results of change in BMI (%) for never smokers and current smokers.  
 
Change in BMI (%) 
between any two 
consecutive surveys 
Never Smokers 
(N = 33,458) 
 
Current Smokers 
























Standard errors are in parentheses. 































Appendix 3.C Intervention Descriptions  
 
1. Pharmacotherapy Intervention [37] 
 
This randomized, double-blind, parallel-group, placebo- and active-controlled clinical trial was 
conducted at 7 US sites from February 2000 to January 2003. Randomized subjects received 1 of 
3 varenicline tartrate dose regiments, sustained-release bupropion hydrochloride or matched 
placebo. Bupropion hydrochloride was dosed for 7 weeks, with titration from 150 mg once daily 
(days 1-3) to 150 mg twice daily through week 7. Subjects who volunteered to join the non-drug 
treatment received clinic visits at week 12, 24 and 52. A total of 638 individuals participated in 
the randomized clinical trial and 353 completed all clinic visits, where 66 were in the placebo 
group and 68 were in the bupropion treatment group.  
 
Mean weight gain from baseline to week 7 was 4 kg for the placebo group, 2.47 kg for the 0.3 mg 
once daily varenicline group, 2.14 kg for the 1 mg once daily group, 1.96 kg for the 1 mg twice 
daily group and 1.68 kg for the bupropion group.  
 
2. Behavioral Intervention [38] 
 
481 participants were recruited in Switzerland between June 2002 and January 2006 in a two-arm, 
randomized controlled trial to quit smoking. The two arms are the physical activity group and the 
control group. Participants in both groups attended a 9-week program with weekly sessions that 
included smoking cessation intervention with nicotine replacement products and counselling. In 
addition to the smoking cessation intervention, the physical activity group followed a 9-week 
physical activity intervention with structured and lifestyle components. Three follow-up visits 
were conducted at week 10, 26 and 52 after the beginning of the smoking cessation intervention.  
 
There was a total of 229 individuals in the physical activity group and 252 in the control group. 
127 and 155 were successfully followed-up at 1 year for the physical activity and control group, 
respectively. At week 52, the weight gain was 3.1 kg (sd = 0.5) in the physical activity group and 
3.7 kg (sd = 0.3) for the control group from baseline. For carbon monoxide (CO) verified sustained 
quitters at week 52, the average weight gain was 4.4 kg (sd = 0.9) in the physical activity group 




3. Electronic cigarettes [33] 
 
Authors conducted a medical records review of patients with cardiorespiratory conditions regularly 
followed-up at the outpatient clinics of four Italian hospitals, over a period of around 3.5 years 
(March 2012 to December 2015). Electronic cigarette users reported at least use on two 
consecutive follow-up visits.  Data from three clinic visits were collected and analyzed. Follow-
up visit 1 and follow-up visit 2 were carried out at 6 months and 12 months after baseline visits, 
respectively.  
 
This study included a total of 223 subjects. These individuals were divided into four major groups: 
1. EC users (exclusive users and dual users); 2. Regular smokers (non-EC); 3. Quitters: subjects 
who reported sustained smoking abstinence after completing a cessation program; 4. Exclusive EC 
users.  Exclusive EC users are those who do not smoke cigarettes while dual users are those who 
report EC use in combination with cigarette smoking. Dual usage was reported by approximately 
50% of EC users in group 1. Quitters experienced on average 4.5% weight gain from baseline in 
12 months while EC users (including dual users) put on only 1.5% of baseline weight. At 12 



























Appendix 3.D Model outcomes in one-year increments in Scenario I. 
 
Figure 3.D.1 Average cumulative survival probability under the NHIS sample in Scenario I, status 
quo vs electronic cigarette.  
 
 
Figure 3.D.2 Average cumulative survival probability under the NHIS sample in Scenario I, status 
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Figure 3.D.3 Average obesity prevalence under the NHIS sample in Scenario I, status quo vs 




Figure 3.D.4 Average obesity prevalence under the NHIS sample in Scenario I, status quo vs 
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Appendix 3.E Model outcomes in one-year increments in Scenario II. 
Figure 3.E.1 Average cumulative survival probability under the random sample in Scenario II, 




Figure 3.E.2 Average cumulative survival probability under the random sample in Scenario II, 


































































Figure 3.E.3 Average cumulative survival probability under the random sample in Scenario II, 

































































Figure 3.E.5 Average obesity prevalence under the random sample in Scenario II, status quo vs 




Figure 3.E.6 Average obesity prevalence under the random sample in Scenario II, status quo vs 






















































Figure 3.E.7 Average cumulative survival probability under the NHIS sample in Scenario II, status 




Figure 3.E.8 Average cumulative survival probability under the NHIS sample in Scenario II, status 
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Figure 3.E.9 Average cumulative survival probability under the NHIS sample in Scenario II, status 
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Figure 3.E.11 Average obesity prevalence under the NHIS sample in Scenario II, status quo vs 




Figure 3.E.12 Average obesity prevalence under the NHIS sample in Scenario II, status quo vs 
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